Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis

The limitations of traditional cancer treatments are driving the creation and development of new nanomedicines. At present, with the rapid increase of research on nanomedicine in the field of cancer, there is a lack of intuitive analysis of the development trend, main authors and research hotspots o...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 352; pp. 211 - 241
Main Authors Pei, Zerong, Chen, Shuting, Ding, Liqin, Liu, Jingbo, Cui, Xinyi, Li, Fengyun, Qiu, Feng
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.12.2022
Subjects
bibliometric analysis
Bibliometrics
biocompatible materials
Cancer
China
Humans
Immunotherapy
India
Nanomedicine
Nanoparticle
Neoplasms - therapy
Tumor Microenvironment
United States
Visualization
United States
China
India
Visualization
Bibliometrics
Nanoparticle
Nanomedicine
Immunotherapy
Cancer
Online AccessGet full text
ISSN0168-3659
1873-4995
1873-4995
DOI10.1016/j.jconrel.2022.10.023

Cover

Abstract The limitations of traditional cancer treatments are driving the creation and development of new nanomedicines. At present, with the rapid increase of research on nanomedicine in the field of cancer, there is a lack of intuitive analysis of the development trend, main authors and research hotspots of nanomedicine in the field of cancer, as well as detailed elaboration of possible research hotspots. In this review, data collected from the Web of Science Core Collection database between January 1st, 2000, and December 31st, 2021, were subjected to a bibliometric analysis. The co-authorship, co-citation, and co-occurrence of countries, institutions, authors, literature, and keywords in this subject were examined using VOSviewer, Citespace, and a well-known online bibliometrics platform. We collected 19,654 published papers, China produced the most publications (36.654%, 7204), followed by the United States (29.594%, 5777), and India (7.780%, 1529). An interesting fact is that, despite China having more publications than the United States, the United States still dominates this field, having the highest H-index and the most citations. Acs Nano, Nano Letters, and Biomaterials are the top three academic publications that publish articles on nanomedicine for cancer out of a total of 7580 academic journals. The most significant increases were shown for the keywords “cancer nanomedicine”, “tumor microenvironment”, “nanoparticles”, “prodrug”, “targeted nanomedicine”, “combination”, and “cancer immunotherapy” indicating the promising area of research. Meanwhile, the development prospects and challenges of nanomedicine in cancer are also discussed and provided some solutions to the major obstacles. [Display omitted] •Data of current nanomedicine in cancer were collected from the Web of Science.•Collected data were systematically analyzed through bibliometric analysis.•Many keywords of nanomedicine in cancer were intuitively analyzed.•Hotspots, emerging frontiers and trend of nanomedicine in cancer were investigated.•Development prospects and challenges of nanomedicine in cancer were discussed.
AbstractList The limitations of traditional cancer treatments are driving the creation and development of new nanomedicines. At present, with the rapid increase of research on nanomedicine in the field of cancer, there is a lack of intuitive analysis of the development trend, main authors and research hotspots of nanomedicine in the field of cancer, as well as detailed elaboration of possible research hotspots. In this review, data collected from the Web of Science Core Collection database between January 1st, 2000, and December 31st, 2021, were subjected to a bibliometric analysis. The co-authorship, co-citation, and co-occurrence of countries, institutions, authors, literature, and keywords in this subject were examined using VOSviewer, Citespace, and a well-known online bibliometrics platform. We collected 19,654 published papers, China produced the most publications (36.654%, 7204), followed by the United States (29.594%, 5777), and India (7.780%, 1529). An interesting fact is that, despite China having more publications than the United States, the United States still dominates this field, having the highest H-index and the most citations. Acs Nano, Nano Letters, and Biomaterials are the top three academic publications that publish articles on nanomedicine for cancer out of a total of 7580 academic journals. The most significant increases were shown for the keywords "cancer nanomedicine", "tumor microenvironment", "nanoparticles", "prodrug", "targeted nanomedicine", "combination", and "cancer immunotherapy" indicating the promising area of research. Meanwhile, the development prospects and challenges of nanomedicine in cancer are also discussed and provided some solutions to the major obstacles.The limitations of traditional cancer treatments are driving the creation and development of new nanomedicines. At present, with the rapid increase of research on nanomedicine in the field of cancer, there is a lack of intuitive analysis of the development trend, main authors and research hotspots of nanomedicine in the field of cancer, as well as detailed elaboration of possible research hotspots. In this review, data collected from the Web of Science Core Collection database between January 1st, 2000, and December 31st, 2021, were subjected to a bibliometric analysis. The co-authorship, co-citation, and co-occurrence of countries, institutions, authors, literature, and keywords in this subject were examined using VOSviewer, Citespace, and a well-known online bibliometrics platform. We collected 19,654 published papers, China produced the most publications (36.654%, 7204), followed by the United States (29.594%, 5777), and India (7.780%, 1529). An interesting fact is that, despite China having more publications than the United States, the United States still dominates this field, having the highest H-index and the most citations. Acs Nano, Nano Letters, and Biomaterials are the top three academic publications that publish articles on nanomedicine for cancer out of a total of 7580 academic journals. The most significant increases were shown for the keywords "cancer nanomedicine", "tumor microenvironment", "nanoparticles", "prodrug", "targeted nanomedicine", "combination", and "cancer immunotherapy" indicating the promising area of research. Meanwhile, the development prospects and challenges of nanomedicine in cancer are also discussed and provided some solutions to the major obstacles.
The limitations of traditional cancer treatments are driving the creation and development of new nanomedicines. At present, with the rapid increase of research on nanomedicine in the field of cancer, there is a lack of intuitive analysis of the development trend, main authors and research hotspots of nanomedicine in the field of cancer, as well as detailed elaboration of possible research hotspots. In this review, data collected from the Web of Science Core Collection database between January 1st, 2000, and December 31st, 2021, were subjected to a bibliometric analysis. The co-authorship, co-citation, and co-occurrence of countries, institutions, authors, literature, and keywords in this subject were examined using VOSviewer, Citespace, and a well-known online bibliometrics platform. We collected 19,654 published papers, China produced the most publications (36.654%, 7204), followed by the United States (29.594%, 5777), and India (7.780%, 1529). An interesting fact is that, despite China having more publications than the United States, the United States still dominates this field, having the highest H-index and the most citations. Acs Nano, Nano Letters, and Biomaterials are the top three academic publications that publish articles on nanomedicine for cancer out of a total of 7580 academic journals. The most significant increases were shown for the keywords "cancer nanomedicine", "tumor microenvironment", "nanoparticles", "prodrug", "targeted nanomedicine", "combination", and "cancer immunotherapy" indicating the promising area of research. Meanwhile, the development prospects and challenges of nanomedicine in cancer are also discussed and provided some solutions to the major obstacles.
The limitations of traditional cancer treatments are driving the creation and development of new nanomedicines. At present, with the rapid increase of research on nanomedicine in the field of cancer, there is a lack of intuitive analysis of the development trend, main authors and research hotspots of nanomedicine in the field of cancer, as well as detailed elaboration of possible research hotspots. In this review, data collected from the Web of Science Core Collection database between January 1st, 2000, and December 31st, 2021, were subjected to a bibliometric analysis. The co-authorship, co-citation, and co-occurrence of countries, institutions, authors, literature, and keywords in this subject were examined using VOSviewer, Citespace, and a well-known online bibliometrics platform. We collected 19,654 published papers, China produced the most publications (36.654%, 7204), followed by the United States (29.594%, 5777), and India (7.780%, 1529). An interesting fact is that, despite China having more publications than the United States, the United States still dominates this field, having the highest H-index and the most citations. Acs Nano, Nano Letters, and Biomaterials are the top three academic publications that publish articles on nanomedicine for cancer out of a total of 7580 academic journals. The most significant increases were shown for the keywords “cancer nanomedicine”, “tumor microenvironment”, “nanoparticles”, “prodrug”, “targeted nanomedicine”, “combination”, and “cancer immunotherapy” indicating the promising area of research. Meanwhile, the development prospects and challenges of nanomedicine in cancer are also discussed and provided some solutions to the major obstacles. [Display omitted] •Data of current nanomedicine in cancer were collected from the Web of Science.•Collected data were systematically analyzed through bibliometric analysis.•Many keywords of nanomedicine in cancer were intuitively analyzed.•Hotspots, emerging frontiers and trend of nanomedicine in cancer were investigated.•Development prospects and challenges of nanomedicine in cancer were discussed.
Author Li, Fengyun
Cui, Xinyi
Chen, Shuting
Liu, Jingbo
Ding, Liqin
Qiu, Feng
Pei, Zerong
Author_xml – sequence: 1
  givenname: Zerong
  surname: Pei
  fullname: Pei, Zerong
  organization: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
– sequence: 2
  givenname: Shuting
  surname: Chen
  fullname: Chen, Shuting
  organization: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
– sequence: 3
  givenname: Liqin
  surname: Ding
  fullname: Ding, Liqin
  organization: State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
– sequence: 4
  givenname: Jingbo
  surname: Liu
  fullname: Liu, Jingbo
  organization: College of Horticulture and Landscape Architecture, Tianjin Agricultural University, Tianjin 300384, China
– sequence: 5
  givenname: Xinyi
  surname: Cui
  fullname: Cui, Xinyi
  organization: College of Horticulture and Landscape Architecture, Tianjin Agricultural University, Tianjin 300384, China
– sequence: 6
  givenname: Fengyun
  surname: Li
  fullname: Li, Fengyun
  email: lifengyun0518@163.com
  organization: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
– sequence: 7
  givenname: Feng
  surname: Qiu
  fullname: Qiu, Feng
  email: fengqiu20070118@163.com
  organization: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36270513$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtvGyEUhVGVqnHS_oRWLLMZl8cAQ7OILKsvKVI37a4SYuCOhDUGF3Ci_Pvg2tlk4xXo6DuXyzlX6CKmCAh9pGRJCZWfN8uNSzHDvGSEsaYtCeNv0IIOine91uICLRo3dFwKfYmuStkQQgTv1Tt0ySVTRFC-QH_X-5whVryDXHbganiAgm30uDbZ4zThaGPagg8uRMAhYmejg_wFr3CGhwCP_-kxjHNoWM3BNcHOTyWU9-jtZOcCH07nNfrz7evv9Y_u_tf3n-vVfee4HmrXT7oXdpzUwBSd6EC97-WouNCgJ66VFIKBIISLdpUT87IfqJBWajaCHwm_RjfHubuc_u2hVLMNxcE82whpXwyngg9MKkbPokwxJXvWlmjopxO6H9v_zS6Hrc1P5iW8BtweAZdTKRkm40K1NaRYsw2zocQcqjIbc6rKHKo6yK2q5hav3C8PnPPdHX3QEm35Z1NcgFaJD7n1Z3wKZyY8A1h8r4w
CitedBy_id crossref_primary_10_1016_j_envres_2023_117027
crossref_primary_10_1007_s00170_024_14793_0
crossref_primary_10_1016_j_heliyon_2024_e36187
crossref_primary_10_2217_nnm_2023_0346
crossref_primary_10_1186_s12951_023_02033_8
crossref_primary_10_2147_IJN_S432407
crossref_primary_10_1002_smll_202405752
crossref_primary_10_1016_j_heliyon_2024_e37439
crossref_primary_10_3389_fneur_2023_1285908
crossref_primary_10_3389_fonc_2024_1343533
crossref_primary_10_3389_fcimb_2024_1388360
crossref_primary_10_1186_s12967_024_05845_w
crossref_primary_10_1080_21645515_2024_2403170
crossref_primary_10_3389_fendo_2023_1231520
crossref_primary_10_1016_j_biopha_2023_115741
crossref_primary_10_4330_wjc_v17_i1_102409
crossref_primary_10_3389_fimmu_2024_1475062
crossref_primary_10_1089_ten_tec_2023_0013
crossref_primary_10_1021_acsomega_4c10893
crossref_primary_10_1016_j_heliyon_2024_e29199
crossref_primary_10_3389_fimmu_2023_1301545
crossref_primary_10_1515_ntrev_2024_0108
crossref_primary_10_2174_0115734137275111231206072049
crossref_primary_10_1007_s00210_024_03112_9
crossref_primary_10_1016_j_microc_2023_109709
crossref_primary_10_1097_MD_0000000000037807
crossref_primary_10_53941_rmd_2025_100004
crossref_primary_10_1016_j_heliyon_2023_e21227
crossref_primary_10_1016_j_jclepro_2024_143895
crossref_primary_10_1016_j_compbiomed_2023_107867
crossref_primary_10_3389_fphar_2024_1388253
crossref_primary_10_1016_j_colsurfa_2024_134961
crossref_primary_10_3390_pharmaceutics17040409
crossref_primary_10_3389_fphar_2023_1258937
crossref_primary_10_1016_j_autrev_2024_103689
crossref_primary_10_2174_0118715303271117231220072051
crossref_primary_10_1016_j_heliyon_2024_e38475
crossref_primary_10_1016_j_ejps_2023_106688
crossref_primary_10_1007_s13577_023_01018_x
crossref_primary_10_3390_pharmaceutics16121582
crossref_primary_10_1016_j_heliyon_2024_e24649
crossref_primary_10_1186_s13019_024_03238_0
crossref_primary_10_1002_cmdc_202400410
crossref_primary_10_1016_j_ijft_2024_100777
crossref_primary_10_1007_s12187_024_10125_6
crossref_primary_10_2147_JMDH_S477219
crossref_primary_10_1016_j_radphyschem_2023_110835
crossref_primary_10_3389_fcell_2023_1146963
crossref_primary_10_1186_s12951_024_02644_9
crossref_primary_10_3389_fphar_2024_1523052
crossref_primary_10_3389_fmicb_2024_1490849
crossref_primary_10_3389_fbioe_2023_1253048
crossref_primary_10_1016_j_apsb_2025_02_022
crossref_primary_10_1007_s11095_024_03676_4
crossref_primary_10_1021_acs_jafc_4c12450
crossref_primary_10_1097_XEB_0000000000000455
crossref_primary_10_1021_jacs_4c18304
crossref_primary_10_1016_j_pharmthera_2024_108656
crossref_primary_10_2147_JPR_S442151
crossref_primary_10_3389_fnins_2023_1128851
crossref_primary_10_1002_pat_70130
crossref_primary_10_3390_pathogens14030289
crossref_primary_10_1016_j_jconrel_2025_02_076
crossref_primary_10_1016_j_heliyon_2023_e23113
crossref_primary_10_4239_wjd_v15_i7_1627
crossref_primary_10_1016_j_ijbiomac_2024_136483
crossref_primary_10_56941_odutip_1442818
crossref_primary_10_3389_fonc_2024_1405351
crossref_primary_10_1007_s00210_024_03258_6
crossref_primary_10_1007_s42823_024_00805_2
crossref_primary_10_3389_fimmu_2024_1478773
crossref_primary_10_3390_pharmaceutics16101339
crossref_primary_10_3389_fphar_2023_1232114
crossref_primary_10_1007_s10143_025_03473_6
crossref_primary_10_3389_fmicb_2024_1342356
crossref_primary_10_3389_fphar_2024_1366852
crossref_primary_10_1016_j_cclet_2025_110981
crossref_primary_10_1111_iwj_14575
crossref_primary_10_3389_fchem_2024_1492215
crossref_primary_10_3233_ADR_230139
crossref_primary_10_3389_fpls_2023_1092511
crossref_primary_10_3390_pharmaceutics15122770
crossref_primary_10_1016_j_yexcr_2024_114318
crossref_primary_10_1111_jcmm_17677
crossref_primary_10_2147_JIR_S462722
crossref_primary_10_3389_fphar_2024_1409163
crossref_primary_10_1007_s10853_024_10103_x
crossref_primary_10_1016_j_nantod_2023_101961
crossref_primary_10_3389_fmed_2024_1507313
crossref_primary_10_1002_cmdc_202300374
crossref_primary_10_3389_fmicb_2024_1433910
crossref_primary_10_1007_s10238_024_01369_1
crossref_primary_10_1016_j_jddst_2024_105829
crossref_primary_10_1080_17435889_2024_2391267
crossref_primary_10_34133_bmr_0015
crossref_primary_10_1016_j_csite_2023_103005
crossref_primary_10_1002_adtp_202400143
crossref_primary_10_1016_j_fbio_2024_103844
crossref_primary_10_1186_s12645_024_00261_7
crossref_primary_10_1002_adma_202308915
crossref_primary_10_1016_j_biomaterials_2024_123034
crossref_primary_10_1039_D3RA01782F
crossref_primary_10_3390_molecules29163784
crossref_primary_10_2147_IJN_S490400
crossref_primary_10_1002_wnan_1892
crossref_primary_10_1177_20552076251323833
crossref_primary_10_1016_j_jiph_2024_102647
crossref_primary_10_3389_fphar_2024_1477938
crossref_primary_10_1016_S1875_5364_24_60726_0
crossref_primary_10_1016_j_jare_2023_09_018
crossref_primary_10_3389_fonc_2024_1465987
crossref_primary_10_1016_j_drudis_2023_103864
crossref_primary_10_1007_s10853_024_10291_6
crossref_primary_10_1177_17446295241299160
crossref_primary_10_3389_fneur_2024_1442493
crossref_primary_10_1016_j_reth_2024_10_013
Cites_doi 10.2147/IJN.S227805
10.18632/oncotarget.27109
10.1038/s41377-020-00441-1
10.3389/fcell.2021.706286
10.1016/j.jconrel.2020.10.001
10.1038/nnano.2007.387
10.1021/bm4002574
10.1002/smll.202003543
10.1186/s11671-020-03451-5
10.1002/smll.201902022
10.21037/atm-20-4235
10.1039/D0RA07749F
10.1016/j.ejphar.2020.173090
10.3322/caac.21564
10.1038/nri.2016.80
10.1016/j.jcis.2018.12.032
10.1016/j.addr.2013.11.009
10.1158/1538-7445.AM2021-306
10.1039/C6NH00139D
10.1021/acsnano.0c00974
10.1126/science.aau6977
10.1038/s41467-020-14425-7
10.1016/j.ijpharm.2021.121090
10.1126/science.1183021
10.1038/s41586-019-1914-8
10.1016/j.msec.2020.110768
10.1080/1061186X.2018.1547732
10.1007/s00066-018-1336-9
10.1038/nrd3554
10.1021/acs.nanolett.9b04981
10.4155/fdd-2019-0005
10.1002/jps.2600791102
10.1007/978-1-60761-609-2_3
10.1038/s41467-019-11718-4
10.1093/annonc/mdw168
10.1002/jcp.27782
10.3389/fnhum.2019.00259
10.1021/acs.nanolett.7b00995
10.1016/j.jconrel.2015.03.023
10.1038/nrc2981
10.1126/sciadv.1701130
10.1016/j.addr.2017.04.010
10.1021/acsnano.6b04989
10.1016/j.jconrel.2010.08.027
10.1038/nature22341
10.1166/jbn.2019.2661
10.1002/adma.202000013
10.1021/acsnano.0c07495
10.1016/j.ijbiomac.2017.10.113
10.1016/j.ymthe.2017.05.016
10.1038/nm.2198
10.2147/IJN.S175340
10.1016/j.jconrel.2022.08.015
10.1021/nn900002m
10.1186/s11671-018-2661-8
10.1016/j.biomaterials.2018.03.004
10.1038/s41467-019-14036-x
10.1016/j.apsb.2021.05.002
10.1016/j.progpolymsci.2005.09.004
10.1016/j.coi.2013.02.009
10.1038/nnano.2017.57
10.1088/1361-6528/ab9395
10.1016/j.biomaterials.2009.01.005
10.1021/ja2010175
10.1021/acsnano.0c07071
10.1021/acsami.6b11803
10.1016/j.ijmedinf.2020.104274
10.1021/nl100996u
10.1021/nn4017179
10.1016/j.jconrel.2021.09.017
10.1080/10717544.2018.1556359
10.1002/adma.201808303
10.1016/j.phrs.2018.11.005
10.1016/j.jconrel.2013.01.001
10.1038/s41586-019-1922-8
10.1039/C9NR03052B
10.1021/jacs.9b09782
10.1002/anie.201907388
10.1021/nl301934w
10.3389/fimmu.2018.02593
10.1016/j.addr.2017.04.001
10.1016/j.pneurobio.2018.06.006
10.1038/s41563-018-0147-9
10.1002/adfm.201905758
10.3390/ijms21239123
10.1002/adfm.202003757
10.1007/978-3-030-35582-1_8
10.1080/03639045.2016.1185435
10.3390/cancers13051164
10.1158/1535-7163.MCT-17-0981
10.1158/0008-5472.CAN-10-4261
10.1039/D0TB00649A
10.1016/j.actbio.2019.01.025
10.1021/nl2038979
10.3390/polym11111905
10.1016/j.jtbi.2013.03.017
10.1126/science.1108003
10.1016/j.carbon.2019.02.056
10.1039/C6CS00592F
10.1016/j.cbi.2011.12.004
10.2147/IJN.S152742
10.1021/ar5001007
10.1208/s12249-020-01743-8
10.1080/21691401.2020.1725025
10.1016/j.biomaterials.2012.10.002
10.1002/anie.201907380
10.1016/j.carbpol.2017.05.062
10.1111/prd.12376
10.1016/j.addr.2012.02.006
10.1021/nl050074e
10.1038/s41467-022-31579-8
10.1016/j.jhep.2020.10.021
10.1016/j.ejpb.2021.05.014
10.2147/IJN.S134148
10.1021/acsnano.0c04370
10.1007/s13346-017-0377-4
10.1039/C7NR00231A
10.1016/j.jconrel.2018.11.032
10.1021/jacs.5b00795
10.1038/s41392-018-0032-7
10.1038/nri.2015.16
10.1200/JCO.2011.38.0899
10.1021/acsami.9b16150
10.1016/S1734-1140(13)70959-9
10.1016/j.jcis.2019.01.021
10.1158/0008-5472.CAN-06-1501
10.1002/ijc.31562
10.1039/C7CC04932C
10.7150/thno.14184
10.1002/advs.202100556
10.1016/j.biomaterials.2012.04.029
10.1016/j.neulet.2017.02.076
10.2174/1381612821666150923095155
10.4103/1008-682X.171582
10.1016/j.actbio.2019.06.051
10.1002/adma.201404308
10.1038/ncomms13193
10.1016/j.apsb.2016.02.001
10.1517/14712598.2014.920813
10.1038/s41586-019-1635-z
10.1039/D0CC04315J
10.1038/s41551-019-0486-0
10.1038/ncomms15906
10.1038/s41467-019-12142-4
10.1016/j.actbio.2019.12.012
10.2147/IJN.S153795
10.3390/polym3031377
10.1021/acsami.7b07091
10.1002/asi.20317
10.1038/nrc903
10.1016/j.addr.2020.06.005
10.1016/j.ejps.2015.12.014
10.3390/polym13193256
10.1158/1078-0432.CCR-05-0883
10.1021/jacs.8b10047
10.1039/c1cs15246g
10.1021/nl050127s
10.1039/D1NH00637A
10.1111/cas.14328
10.1096/fasebj.1.6.3315809
10.1002/adfm.202005918
10.3390/ijms15033640
10.1080/21691401.2017.1376675
10.1021/acs.nanolett.0c01297
10.1021/nn405830g
10.1021/ja0772086
10.1016/j.ejpb.2012.08.012
10.1111/ipd.12563
10.1016/j.bioactmat.2022.03.009
10.1038/nrc1566
10.1016/j.jconrel.2021.07.018
10.1038/nmat3758
10.1007/s42765-022-00137-8
10.1002/adfm.201805582
10.1007/s12274-008-8021-8
10.1021/nl102184c
10.1039/C8SC04123G
10.1021/nn800072t
10.1038/nmat2614
10.1021/acsnano.9b00326
10.1016/j.biomaterials.2016.09.034
10.1021/acsabm.9b01185
10.1016/j.colsurfb.2015.12.025
10.1002/adfm.201902440
10.1039/C7NR06898K
10.1021/acsnano.6b02231
10.1016/j.biomaterials.2011.12.029
10.1016/j.carbpol.2018.03.097
10.1021/ar200054n
10.1158/0008-5472.CAN-18-0842
10.7150/thno.30853
10.1007/s11192-009-0146-3
10.1002/smll.201600954
10.1371/journal.pbio.3000384
10.1038/nrc.2016.108
10.1002/smll.202004905
10.1002/adfm.201808646
10.1021/nl500618u
10.1002/smll.201803993
10.1016/j.colsurfa.2020.125178
10.1038/s41563-018-0028-2
10.1021/acs.nanolett.6b01632
10.1021/acsnano.8b08346
10.1021/nn800596w
10.1039/c3cs60048c
10.1126/scitranslmed.3003763
10.1038/nrc3565
10.1080/21691401.2018.1489261
10.1021/bc400070q
10.1126/science.aaa8172
10.1021/acs.biomac.9b01742
10.1016/j.colsurfb.2018.11.046
10.1126/science.1178331
10.1039/C8BM01272E
10.1039/C9NR08558K
10.1021/acsami.6b01501
10.1038/35092620
10.1038/nrc1590
10.1021/acs.chemmater.6b01641
10.1016/j.ijpharm.2018.12.023
10.1016/j.colsurfb.2015.06.027
10.1016/S0092-8674(00)81683-9
10.1021/acs.chemrev.5b00589
10.1080/17425247.2016.1201059
10.1126/science.aar3246
10.2174/1573394715666190618121649
10.1021/acs.nanolett.6b00820
10.1111/cbdd.12525
10.1016/j.nantod.2015.06.004
10.1039/D0RA06106A
10.1021/jacs.9b10765
10.1016/j.carbpol.2020.117194
10.1016/j.addr.2015.01.002
10.1038/nnano.2012.237
10.7150/thno.19987
10.1016/j.jconrel.2015.05.124
10.1073/pnas.0608582104
10.1016/j.carbpol.2020.117180
10.1021/acs.analchem.8b05706
10.1021/acs.nanolett.8b00689
10.1021/acs.biomac.9b01578
10.1073/pnas.0307513100
10.1021/nn500216y
10.1016/j.immuni.2014.06.010
ContentType Journal Article
Copyright 2022
Copyright © 2022. Published by Elsevier B.V.
Copyright_xml – notice: 2022
– notice: Copyright © 2022. Published by Elsevier B.V.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.jconrel.2022.10.023
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-4995
EndPage 241
ExternalDocumentID 36270513
10_1016_j_jconrel_2022_10_023
S0168365922006939
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GeographicLocations United States
China
India
GeographicLocations_xml – name: United States
– name: China
– name: India
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29K
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
AABNK
AABXZ
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEZYN
AFKWA
AFRZQ
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
D-I
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPC
SPCBC
SPT
SSM
SSP
SSZ
T5K
TEORI
WUQ
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
ID FETCH-LOGICAL-c398t-4f945abf78271f181dd46b7359e9f3976552e500357656f2d648156a692bedb03
IEDL.DBID .~1
ISSN 0168-3659
1873-4995
IngestDate Fri Jul 11 07:09:55 EDT 2025
Thu Jul 10 18:40:42 EDT 2025
Wed Feb 19 02:26:20 EST 2025
Thu Apr 24 23:12:47 EDT 2025
Tue Jul 01 04:10:08 EDT 2025
Fri Feb 23 02:40:13 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Visualization
Bibliometrics
Nanoparticle
Nanomedicine
Immunotherapy
Cancer
Language English
License Copyright © 2022. Published by Elsevier B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c398t-4f945abf78271f181dd46b7359e9f3976552e500357656f2d648156a692bedb03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 36270513
PQID 2727642181
PQPubID 23479
PageCount 31
ParticipantIDs proquest_miscellaneous_3153826721
proquest_miscellaneous_2727642181
pubmed_primary_36270513
crossref_citationtrail_10_1016_j_jconrel_2022_10_023
crossref_primary_10_1016_j_jconrel_2022_10_023
elsevier_sciencedirect_doi_10_1016_j_jconrel_2022_10_023
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2022
2022-12-00
20221201
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: December 2022
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Journal of controlled release
PublicationTitleAlternate J Control Release
PublicationYear 2022
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Xu, Cui, Huang, Zhang, Zhu, Sun, Cao, Ding, Wang, Gao, Zhang (bb0885) 2018; 14
Krug, Abbassi, Griesmann, Sipos, Wiese, Rexin, Blank, Perren, Haybaeck, Hüttelmaier, Rinke, Gress, Michl (bb1165) 2018; 143
Ni, Jiang, Valdovinos, Ehlerding, Yu, Barnhart, Huang, Cai (bb0320) 2017; 17
Ferrari (bb0045) 2005; 5
Partl, Regitnig, Tauber, Pötscher, Bjelic-Radisic, Kapp (bb0015) 2018; 194
Jin, Pi, Zhao, Jiang, Li, Zeng, Yang, Evans, Cai (bb0965) 2017; 9
Fu, Xiang (bb0845) 2020; 21
Delamarre, Pack, Chang, Mellman, Trombetta (bb1040) 2005; 307
Yunna, Mengru, Lei, Weidong (bb1115) 2020; 877
Bertrand, Wu, Xu, Kamaly, Farokhzad (bb0290) 2014; 66
Gökçe, Castonguay, Temiz, Gervais, Delamarche (bb0465) 2019; 574
Jin, Wen, Hu, Chen, Zheng, Guo, Wang, Qian, Su, He (bb1035) 2017; 9
Shen, Wu, Chen, Hu, Pan, Kong, Lin (bb0175) 2022; 12
Zheng, You, Guan, Huang, Wang, Zhang, Wu (bb0780) 2019; 29
Yong, Zhang, Bie, Zhang, Zhang, Li, Hakeem, Hu, Gan, Santos, Yang (bb0690) 2019; 10
Lou, McDonald, Oloumi, Chia, Ostlund, Ahmadi, Kyle, Auf Keller, Leung, Huntsman, Clarke, Sutherland, Waterhouse, Bally, Roskelley, Overall, Minchinton, Pacchiano, Carta, Scozzafava, Touisni, Winum, Supuran, Dedhar (bb0235) 2011; 71
Li, Wang, Xiang, Liu, Yu, Jiang (bb0900) 2019; 91
Xia, Zhong, Zhao, Tang, Han, Hua, Xu, Wang, Zhu (bb0985) 2019; 26
Caldorera-Moore, Vela Ramirez, Peppas (bb0475) 2019; 27
Chen, Liang, Wang, Liu (bb0825) 2015; 27
Danhier, Feron, Préat (bb0835) 2010; 148
Liao, Bai, Friedman (bb1090) 2013; 328
Gulla, Rao, Moku, Jinka, Nimmu, Khalid, Patra, Chaudhuri (bb1245) 2019; 7
Ge, Liu (bb0705) 2013; 42
Huang, Lv, Wang, Cao, Liu, Liu, Lu (bb0935) 2019; 556
Cabrita, Lauss, Sanna, Donia, Skaarup Larsen, Mitra, Johansson, Phung, Harbst, Vallon-Christersson, van Schoiack, Lövgren, Warren, Jirström, Olsson, Pietras, Ingvar, Isaksson, Schadendorf, Schmidt, Bastholt, Carneiro, Wargo, Svane, Jönsson (bb1230) 2020; 577
Sharma, Allison (bb1030) 2015; 348
Wang, Wang, Chu, Li, Yu, Huang, Xu, Zheng (bb1110) 2021; 74
Tong, He, Ma, Wang, Huang, Cao, Xu, Zou, Wang, Yi, Yin, Wang (bb1140) 2021; 9
Batra, Pawar, Bahl (bb0030) 2019; 139
Chen, Chen, Yang, Xu, Xu, Liang, Han, Liu (bb1070) 2019; 31
Ghosh, Choudhury, Ghosh, Mandal, Sarkar, Ghosh, Saha, Das (bb0535) 2012; 195
Wu, Gao, Zhang, Bai, Cheng, Li, Cui (bb0555) 2020; 9
El-Sayed, Huang, El-Sayed (bb0200) 2005; 5
Zheng, Chang, Lu, Chen, Xie, Nie, He, Zou, Gu (bb0240) 2011; 6
Ruttala, Ramasamy, Gupta, Choi, Yong, Kim (bb0820) 2017; 173
Xiu, Zhang, Puppala, Colvin, Alvarez (bb0220) 2012; 12
Shi, Wang, You, Akhtar, Liu, Han, Li, Wang (bb0730) 2019; 11
Neri, Supuran (bb0350) 2011; 10
Soltantabar, Calubaquib, Mostafavi, Biewer, Stefan (bb0505) 2020; 21
Grill, Shahani, Koniar, Panyam (bb0510) 2018; 8
Patel, Angelos, Dichtel, Coskun, Yang, Zink, Stoddart (bb0315) 2008; 130
Xie, Li, Zhang, Lu, Lian, Lin, Gao, Jia (bb0890) 2016; 83
Jose, A, Sebastian, H, A, Durazzo, Lucarini, Santini, Souto (bb0490) 2019; 11
Yamamoto, Makino, Sato, Noma, Urakawa, Takeoka, Yamashita, Saito, Tanaka, Takahashi, Kurokawa, Yamasaki, Nakajima, Mori, Doki, Wada (bb1105) 2020; 111
Fang, Islam, Maeda (bb0420) 2020; 157
Zhang, Beatty, Lu, Abdalrahman, Makris, Wang, Wang (bb0470) 2020; 111
Shi, Votruba, Farokhzad, Langer (bb0055) 2010; 10
Li, Sobral, Badrinath, Choi, Graveline, Stafford, Weaver, Dellacherie, Shih, Ali, Kim, Wucherpfennig, Mooney (bb1240) 2018; 17
Chen, Dubin, Kim (bb0130) 2014; 14
Maulvi, Desai, Shetty, Shah, Willcox (bb0105) 2021; 608
Liu, Li, Lv, Huang, An, Shi, Ma (bb0495) 2020; 3
Geissmann, Manz, Jung, Sieweke, Merad, Ley (bb1050) 2010; 327
Mi, Cabral, Kataoka (bb0840) 2020; 32
Saha, Xiong, Chakraborty, Shameer, Arvizo, Kudgus, Dwivedi, Hossen, Gillies, Robertson, Dudley, Urrutia, Postier, Bhattacharya, Mukherjee (bb1285) 2016; 10
Gardner, Alatise, Miller, Grant, Alexander-Bryant (bb0595) 2021; 81
Kearney, Mooney (bb0065) 2013; 12
Wang, Wu, Li, Shen, Liu, Wu (bb0775) 2018; 29
Plebanek, Bhaumik, Bryce, Thaxton (bb1300) 2018; 17
Greish (bb0425) 2010; 624
Tao, Zeng, Wu, Zhu, Yu, Zhang, Zhang, Liu, Mei (bb0895) 2016; 6
Gajewski, Woo, Zha, Spaapen, Zheng, Corrales, Spranger (bb1200) 2013; 25
Sun, Qian, Shi, Xu, Liu, Zhou, Zhu, Yue, Yan (bb0770) 2019; 63
Law, Leung, Xu (bb1000) 2020; 48
Li, Hu, Fu, Liu, Wang, Song, Yang (bb0365) 2020; 30
Parayath, Parikh, Amiji (bb1290) 2018; 18
Kim, Dang (bb0340) 2006; 66
Ouyang, Zhang, Xue, Yu, Xu, Wang, Lu, Wu (bb0925) 2020; 142
Farhood, Najafi, Mortezaee (bb1130) 2019; 234
AshaRani, Low Kah Mun, Hande, Valiyaveettil (bb0185) 2009; 3
Li, Lin, He, Lu, Xu, Tao, Xia, Zeng, Mao, Luo, Cai (bb0520) 2020; 14
Hu, Liu (bb0710) 2014; 47
Zhang, Guo, Ding, Pan, Zhu, Zhang (bb0720) 2019; 58
Wang, Han, Dong, Xu, Wang, Liu (bb1060) 2019; 29
van Eck, Waltman (bb0085) 2010; 84
Zhang, Zhang, Ding, Shen, Li, Wagner, Xiao, Chen (bb0360) 2020; 32
Liu, Liu, Yang, Sun, Zhang, Huang, Zhou, Liu, Chu, Huang, Deng, Dong, Liu (bb0930) 2016; 8
Shi, Kantoff, Wooster, Farokhzad (bb0415) 2017; 17
Sobot, Mura, Rouquette, Vukosavljevic, Cayre, Buchy, Pieters, Garcia-Argote, Windbergs, Desmaële, Couvreur (bb0955) 2017; 25
Liu, Zhang, Zhao, Yue, Sun, Ni, Zhong (bb0610) 2022; 350
Ha, Yang, Nadithe (bb0550) 2016; 6
Krummel, Bartumeus, Gérard (bb1180) 2016; 16
Jain, Kesharwani, Garg, Jain, Jain, Jain, Nirbhavane, Ghanghoria, Tyagi, Katare (bb0990) 2015; 134
Speiser, Ho, Verdeil (bb1175) 2016; 16
Trujillo, Long (bb0160) 2018; 4
Iwasaki, Medzhitov (bb1045) 2010; 327
Shi, Xiao, Kamaly, Farokhzad (bb0300) 2011; 44
Suzuki, Kapoor, Jassar, Kaiser, Albelda (bb1305) 2005; 11
Gupta (bb0010) 1990; 79
Makadia, Siegel (bb0260) 2011; 3
Ovais, Guo, Chen (bb1150) 2019; 31
Chu, Qu, He, Hao, Yang, Yang, Hu, Wang, Qian (bb0750) 2020; 30
Nie, Sun, Sun, Zhou, Zhang, Zheng, Wang (bb0920) 2020; 160
Noy, Pollard (bb1085) 2014; 41
Liu, Su (bb0590) 2019; 9
Yu, Li, Zhang, Gu, Zhong, Zha, Yang, Zhu, Chen (bb0125) 2020; 8
Hanahan, Weinberg (bb0040) 2000; 100
Chen (bb0140) 2004; 101
Wang, Mooney (bb1080) 2018; 17
Stephan, Stephan, Bak, Chen, Irvine (bb1260) 2012; 33
Sharma, Liaw, Sharma, Jimenez, Chang, Salazar, Amlani, Kannan, Kannan (bb0625) 2021; 337
Stephan, Moon, Um, Bershteyn, Irvine (bb1255) 2010; 16
Strand, Krasnick, Pan, Zhang, Bi, Brooks, Wetzel, Sankpal, Fleming, Goedegebuure, DeNardo, Gillanders, Hawkins, Wickline, Fields (bb0485) 2019; 10
Zhang, Hao, Yao, Tang, Guo, Cong, Li, Bao, Wang, Li, Yu, Duan, Yao (bb0575) 2021; 17
Wang, Peng, Peng, Tan (bb0910) 2020; 14
Sacchetti, Rapini, Magrini, Cirelli, Bellucci, Mattei, Rosato, Bottini, Bottini (bb1295) 2013; 24
Zhou, Chen, Cao, Gao (bb1330) 2020; 8
Lu, Long, Wang, Wang, Xia, Li, Zhang, He (bb1015) 2021; 165
Chen, Liu, Clayman, Shao, Xiao, Tian, Fu, Zhang, Ruan, Zhou, Liu, Wang, Rui (bb0400) 2015; 86
Zhang, Gao, Yang, Yang, Yu, Wang, Shi, Shen (bb0665) 2022; 4
Khanna, Kalscheuer, Kirtane, Zhang, Panyam (bb0875) 2019; 1
Fang, Hu, Luk, Gao, Copp, Tai, O’Connor, Zhang (bb1075) 2014; 14
Luo, Sun, Liu, Sun, Miao, Musetti, Li, Han, Du, Li, Huang, He (bb0760) 2016; 16
Maeda (bb0295) 2015; 91
Swartz, Hirosue, Hubbell (bb0060) 2012; 4
Ye, Wang, Hu, Hochu, Xin, Wang, Gu (bb1315) 2016; 10
Smith, Stephan, Moffett, McKnight, Ji, Reiman, Bonagofski, Wohlfahrt, Pillai, Stephan (bb1185) 2017; 12
Allen (bb0020) 2002; 2
Ernsting, Hoang, Lohse, Undzys, Cao, Do, Gill, Pintilie, Hedley, Li (bb1280) 2015; 206
Liao, Ho, Lin, Naveen Raj, Liu, Chen, Zhou, Lu, Chao (bb0865) 2019; 86
Wang, Xu, Liang, Liu, Li, Yang, Cheng, Li, Liu (bb0330) 2013; 7
Chen, Guo, Wang, Gong, Kong, Xia, Chen (bb0335) 2013; 34
Higaki, Uetani, Ikeda, Yamaguchi (bb0155) 2020; 143
Wen, Yu, Wu, Huang, Qiu, Ren, Zhu, Chen (bb0620) 2022; 18
Li, Lock, Mills, Ou, Morrow, Stern, Wang, Anderson, Xu, Ghose, Li, Cui (bb0450) 2020; 20
Gao, Zhang, Fu, Xie, Peng, You, Tang, Wang, Li, Chen (bb0975) 2017; 12
Coon, Stephan, Gupta, Kealey, Stephan (bb1210) 2020; 4
Agarwal, Durairajanayagam, Tatagari, Esteves, Harlev, Henkel, Roychoudhury, Homa, Puchalt, Ramasamy, Majzoub, Ly, Tvrda, Assidi, Kesari, Sharma, Banihani, Ko, Abu-Elmagd, Gosalvez, Bashiri (bb0080) 2016; 18
Shen, Cai, Ma, Xu, Huo, Song, Qiu, Zhang, Li, Cao, Zhou, Tang (bb0870) 2020; 15
Yang, Hou, Zhang, Wang, Liu, Huang, Liu (bb0615) 2021; 339
Salvati, Pitek, Monopoli, Prapainop, Bombelli, Hristov, Kelly, Åberg, Mahon, Dawson (bb0225) 2013; 8
Afsharzadeh, Hashemi, Mokhtarzadeh, Abnous, Ramezani (bb0500) 2018; 46
Mrowczynski, Zacharia, Connor (bb0560) 2019; 172
Mortimer, Butcher, Musumeci, Deng, Martin, Minchin (bb0580) 2014; 8
Ma, Jemal, Fedewa, Islami, Lichtenfeld, Wender, Cullen, Brawley (bb0005) 2019; 69
Xu, Wang, Zhang, Huang (bb1275) 2014; 8
Bu, Rao, Yu, Chen, Deng, Liu, Wu, Meng, Guo, Zhao, Zhang, Chen, Gu, Liu (bb0650) 2019; 29
Liu, Hu, Zhu, Yu, Talebian, Bai (bb1095) 2020; 1223
Shi, Lu, Wang, Belhadj, Wang, Zhang (bb0715) 2021; 11
Zhang, Lin, Pei, Hu, Xie, Jing (bb0740) 2016; 28
Ulbrich, Holá, Šubr, Bakandritsos, Tuček, Zbořil (bb0075) 2016; 116
Zawilska, Wojcieszak, Olejniczak (bb0700) 2013; 65
He, Xiong, He, Sun, Huang, Ren, Wu, Laurence, Patterson, Zhang (bb0950) 2020; 31
Yang, Zhang, Zhang, Sun, Lee, Liu (bb0190) 2010; 10
Hu, Zhang, Yu, Tu, Yang, Wang, Hu, Kong, Zhang (bb0685) 2020; 16
Li, Huang, Huang, Jiang, Wang, Zhang, Jiang, Xiang, Chen, Nie, Gui (bb0655) 2019; 146
Fadeev, Kozlovskiy, Korolkov, Egizbek, Nazarova, Chudoba, Rusakov, Zdorovets (bb0275) 2020; 603
Chan, Chang, Huang, Lee, Liu, Hsiao (bb0565) 2022; 7
Kalluri, LeBleu (bb0545) 2020; 367
Li, Gao, Fu, Chen, Meng, Fan, Kong, Wang, Zhao (bb0785) 2016; 140
Salvador-Morales, Zhang, Langer, Farokhzad (bb0285) 2009; 30
Helmink, Reddy, Gao, Zhang, Basar, Thakur, Yizhak, Sade-Feldman, Blando, Han, Gopalakrishnan, Xi, Zhao, Amaria, Tawbi, Cogdill, Liu, LeBleu, Kugeratski, Patel, Davies, Hwu, Lee, Gershenwald, Lucci, Arora, Woodman, Keung, Gaudreau, Reuben, Spencer, Burton, Haydu, Lazar, Zapassodi, Hudgens, Ledesma, Ong, Bailey, Warren, Rao, Krijgsman, Rozeman, Peeper, Blank, Schumacher, Butterfield, Zelazowska, McBride, Kalluri, Allison, Petitprez, Fridman, Sautès-Fridman, Hacohen, Rezvani, Sharma, Tetzlaff, Wang, Wargo (bb1225) 2020; 577
Kershaw, Westwood, Darcy (bb1025) 2013; 13
Smith (bb0070) 2013; 14
L
Chandler (10.1016/j.jconrel.2022.10.023_bb0405) 2021; 22
Yu (10.1016/j.jconrel.2022.10.023_bb0125) 2020; 8
Janagam (10.1016/j.jconrel.2022.10.023_bb0100) 2017; 122
Chen (10.1016/j.jconrel.2022.10.023_bb0310) 2013; 169
Shi (10.1016/j.jconrel.2022.10.023_bb0055) 2010; 10
Luo (10.1016/j.jconrel.2022.10.023_bb0540) 2012; 82
Li (10.1016/j.jconrel.2022.10.023_bb1320) 2020; 12
Krummel (10.1016/j.jconrel.2022.10.023_bb1180) 2016; 16
Li (10.1016/j.jconrel.2022.10.023_bb0900) 2019; 91
Xiao (10.1016/j.jconrel.2022.10.023_bb0905) 2019; 141
Kim (10.1016/j.jconrel.2022.10.023_bb0340) 2006; 66
Sun (10.1016/j.jconrel.2022.10.023_bb0770) 2019; 63
Knight (10.1016/j.jconrel.2022.10.023_bb0480) 2019; 13
Aranaz (10.1016/j.jconrel.2022.10.023_bb0265) 2021; 13
Kalluri (10.1016/j.jconrel.2022.10.023_bb0545) 2020; 367
Smith (10.1016/j.jconrel.2022.10.023_bb0070) 2013; 14
Zou (10.1016/j.jconrel.2022.10.023_bb0940) 2018; 3
Shen (10.1016/j.jconrel.2022.10.023_bb0175) 2022; 12
Higaki (10.1016/j.jconrel.2022.10.023_bb0155) 2020; 143
Cairns (10.1016/j.jconrel.2022.10.023_bb0345) 2011; 11
Fu (10.1016/j.jconrel.2022.10.023_bb0845) 2020; 21
Lou (10.1016/j.jconrel.2022.10.023_bb0235) 2011; 71
Zhou (10.1016/j.jconrel.2022.10.023_bb1330) 2020; 8
Huang (10.1016/j.jconrel.2022.10.023_bb1215) 2020; 11
Choi (10.1016/j.jconrel.2022.10.023_bb1120) 2018; 33
Li (10.1016/j.jconrel.2022.10.023_bb1240) 2018; 17
Gulla (10.1016/j.jconrel.2022.10.023_bb1245) 2019; 7
Swartz (10.1016/j.jconrel.2022.10.023_bb0060) 2012; 4
Liu (10.1016/j.jconrel.2022.10.023_bb0930) 2016; 8
Ge (10.1016/j.jconrel.2022.10.023_bb0705) 2013; 42
Battaglia (10.1016/j.jconrel.2022.10.023_bb0095) 2016; 13
Dean (10.1016/j.jconrel.2022.10.023_bb0230) 2005; 5
Chu (10.1016/j.jconrel.2022.10.023_bb0750) 2020; 30
Fadeev (10.1016/j.jconrel.2022.10.023_bb0275) 2020; 603
Zhang (10.1016/j.jconrel.2022.10.023_bb0740) 2016; 28
Gentile (10.1016/j.jconrel.2022.10.023_bb0255) 2014; 15
Zhang (10.1016/j.jconrel.2022.10.023_bb0470) 2020; 111
Sockolosky (10.1016/j.jconrel.2022.10.023_bb1220) 2018; 359
Cabrita (10.1016/j.jconrel.2022.10.023_bb1230) 2020; 577
Saha (10.1016/j.jconrel.2022.10.023_bb1285) 2016; 10
Stuart (10.1016/j.jconrel.2022.10.023_bb0325) 2010; 9
Strand (10.1016/j.jconrel.2022.10.023_bb0485) 2019; 10
Yin (10.1016/j.jconrel.2022.10.023_bb0735) 2020; 21
Salvati (10.1016/j.jconrel.2022.10.023_bb0225) 2013; 8
Rwei (10.1016/j.jconrel.2022.10.023_bb0380) 2015; 10
Zhao (10.1016/j.jconrel.2022.10.023_bb0435) 2014; 10
Perazzo (10.1016/j.jconrel.2022.10.023_bb0115) 2019; 29
Yunna (10.1016/j.jconrel.2022.10.023_bb1115) 2020; 877
Chen (10.1016/j.jconrel.2022.10.023_bb0130) 2014; 14
Zheng (10.1016/j.jconrel.2022.10.023_bb0780) 2019; 29
Robinson (10.1016/j.jconrel.2022.10.023_bb0205) 2011; 133
Shi (10.1016/j.jconrel.2022.10.023_bb0730) 2019; 11
Lv (10.1016/j.jconrel.2022.10.023_bb1270) 2017; 13
Chen (10.1016/j.jconrel.2022.10.023_bb0335) 2013; 34
Ernsting (10.1016/j.jconrel.2022.10.023_bb1280) 2015; 206
Zhang (10.1016/j.jconrel.2022.10.023_bb0360) 2020; 32
Steffes (10.1016/j.jconrel.2022.10.023_bb0430) 2020; 12
Helmink (10.1016/j.jconrel.2022.10.023_bb1225) 2020; 577
Shen (10.1016/j.jconrel.2022.10.023_bb0870) 2020; 15
Tian (10.1016/j.jconrel.2022.10.023_bb0640) 2016; 1
Chen (10.1016/j.jconrel.2022.10.023_bb1070) 2019; 31
Jose (10.1016/j.jconrel.2022.10.023_bb0490) 2019; 11
Hu (10.1016/j.jconrel.2022.10.023_bb0710) 2014; 47
Chowdhury (10.1016/j.jconrel.2022.10.023_bb0915) 2020; 21
Ferrari (10.1016/j.jconrel.2022.10.023_bb0045) 2005; 5
Wan (10.1016/j.jconrel.2022.10.023_bb0370) 2019; 58
Fomina (10.1016/j.jconrel.2022.10.023_bb0375) 2012; 64
Fang (10.1016/j.jconrel.2022.10.023_bb1075) 2014; 14
Ghosh (10.1016/j.jconrel.2022.10.023_bb0535) 2012; 195
Wang (10.1016/j.jconrel.2022.10.023_bb0630) 2022; 13
Liao (10.1016/j.jconrel.2022.10.023_bb0865) 2019; 86
Wang (10.1016/j.jconrel.2022.10.023_bb0330) 2013; 7
Liu (10.1016/j.jconrel.2022.10.023_bb1160) 2020; 16
Yang (10.1016/j.jconrel.2022.10.023_bb0615) 2021; 339
Speiser (10.1016/j.jconrel.2022.10.023_bb1175) 2016; 16
Cai (10.1016/j.jconrel.2022.10.023_bb0515) 2020; 10
Sun (10.1016/j.jconrel.2022.10.023_bb0180) 2008; 1
Wang (10.1016/j.jconrel.2022.10.023_bb0775) 2018; 29
Pitt (10.1016/j.jconrel.2022.10.023_bb1205) 2016; 27
Xu (10.1016/j.jconrel.2022.10.023_bb1275) 2014; 8
Xie (10.1016/j.jconrel.2022.10.023_bb0890) 2016; 83
Ni (10.1016/j.jconrel.2022.10.023_bb0320) 2017; 17
Neri (10.1016/j.jconrel.2022.10.023_bb0350) 2011; 10
Chen (10.1016/j.jconrel.2022.10.023_bb0455) 2020; 14
Shi (10.1016/j.jconrel.2022.10.023_bb0415) 2017; 17
Maulvi (10.1016/j.jconrel.2022.10.023_bb0105) 2021; 608
Bai (10.1016/j.jconrel.2022.10.023_bb0790) 2018; 193
Chen (10.1016/j.jconrel.2022.10.023_bb1055) 2016; 7
Colzani (10.1016/j.jconrel.2022.10.023_bb1250) 2018; 13
Tan (10.1016/j.jconrel.2022.10.023_bb0830) 2015; 137
Mrowczynski (10.1016/j.jconrel.2022.10.023_bb0560) 2019; 172
Shi (10.1016/j.jconrel.2022.10.023_bb0715) 2021; 11
Miller (10.1016/j.jconrel.2022.10.023_bb0810) 2017; 28
Liong (10.1016/j.jconrel.2022.10.023_bb0215) 2008; 2
Liu (10.1016/j.jconrel.2022.10.023_bb0495) 2020; 3
Xu (10.1016/j.jconrel.2022.10.023_bb0885) 2018; 14
Sharma (10.1016/j.jconrel.2022.10.023_bb0625) 2021; 337
Li (10.1016/j.jconrel.2022.10.023_bb0605) 2019; 96
Geissmann (10.1016/j.jconrel.2022.10.023_bb1050) 2010; 327
Cao (10.1016/j.jconrel.2022.10.023_bb0945) 2019; 15
Luo (10.1016/j.jconrel.2022.10.023_bb0760) 2016; 16
Danhier (10.1016/j.jconrel.2022.10.023_bb0835) 2010; 148
Li (10.1016/j.jconrel.2022.10.023_bb0655) 2019; 146
Ioannidis (10.1016/j.jconrel.2022.10.023_bb0170) 2019; 17
Li (10.1016/j.jconrel.2022.10.023_bb0450) 2020; 20
Tousi (10.1016/j.jconrel.2022.10.023_bb0660) 2021; 11
Zawilska (10.1016/j.jconrel.2022.10.023_bb0700) 2013; 65
Liu (10.1016/j.jconrel.2022.10.023_bb0590) 2019; 9
Ouyang (10.1016/j.jconrel.2022.10.023_bb0925) 2020; 142
Li (10.1016/j.jconrel.2022.10.023_bb0520) 2020; 14
AshaRani (10.1016/j.jconrel.2022.10.023_bb0185) 2009; 3
Maeda (10.1016/j.jconrel.2022.10.023_bb0295) 2015; 91
Pineda-Reyes (10.1016/j.jconrel.2022.10.023_bb0445) 2021; 11
Duan (10.1016/j.jconrel.2022.10.023_bb0850) 2018; 13
Zhang (10.1016/j.jconrel.2022.10.023_bb0720) 2019; 58
Coon (10.1016/j.jconrel.2022.10.023_bb1210) 2020; 4
Loo (10.1016/j.jconrel.2022.10.023_bb0210) 2005; 5
Fujita (10.1016/j.jconrel.2022.10.023_bb0035) 2014; 72
Li (10.1016/j.jconrel.2022.10.023_bb0670) 2021; 33
Xiu (10.1016/j.jconrel.2022.10.023_bb0220) 2012; 12
Du (10.1016/j.jconrel.2022.10.023_bb0390) 2020; 30
He (10.1016/j.jconrel.2022.10.023_bb0950) 2020; 31
Son (10.1016/j.jconrel.2022.10.023_bb0880) 2018; 110
Tang (10.1016/j.jconrel.2022.10.023_bb0245) 2018; 166
Dong (10.1016/j.jconrel.2022.10.023_bb0120) 2019; 13
Xia (10.1016/j.jconrel.2022.10.023_bb0985) 2019; 26
Plebanek (10.1016/j.jconrel.2022.10.023_bb1300) 2018; 17
Iwasaki (10.1016/j.jconrel.2022.10.023_bb1045) 2010; 327
Chan (10.1016/j.jconrel.2022.10.023_bb0565) 2022; 7
Wang (10.1016/j.jconrel.2022.10.023_bb0795) 2020; 14
Mohamed (10.1016/j.jconrel.2022.10.023_bb0600) 2021; 252
Dai (10.1016/j.jconrel.2022.10.023_bb0355) 2017; 46
Zhang (10.1016/j.jconrel.2022.10.023_bb0525) 2018; 46
Li (10.1016/j.jconrel.2022.10.023_bb0270) 2012; 41
Lu (10.1016/j.jconrel.2022.10.023_bb1015) 2021; 165
Caldorera-Moore (10.1016/j.jconrel.2022.10.023_bb0475) 2019; 27
Jain (10.1016/j.jconrel.2022.10.023_bb0990) 2015; 134
Wu (10.1016/j.jconrel.2022.10.023_bb0145) 2021; 12
Zhao (10.1016/j.jconrel.2022.10.023_bb0995) 2019; 540
Chen (10.1016/j.jconrel.2022.10.023_bb0400) 2015; 86
El-Sayed (10.1016/j.jconrel.2022.10.023_bb0200) 2005; 5
Huang (10.1016/j.jconrel.2022.10.023_bb0935) 2019; 556
Yang (10.1016/j.jconrel.2022.10.023_bb1235) 2019; 13
Meng (10.1016/j.jconrel.2022.10.023_bb0970) 2020; 11
Brown (10.1016/j.jconrel.2022.10.023_bb0250) 2001; 413
Liu (10.1016/j.jconrel.2022.10.023_bb0610) 2022; 350
Andrade (10.1016/j.jconrel.2022.10.023_bb0460) 2021; 13
Parayath (10.1016/j.jconrel.2022.10.023_bb1290) 2018; 18
Dong (10.1016/j.jconrel.2022.10.023_bb0635) 2016; 8
Fang (10.1016/j.jconrel.2022.10.023_bb0420) 2020; 157
Liu (10.1016/j.jconrel.2022.10.023_bb0980) 2017; 53
Batra (10.1016/j.jconrel.2022.10.023_bb0030) 2019; 139
Wang (10.1016/j.jconrel.2022.10.023_bb1125) 2017; 112
Gupta (10.1016/j.jconrel.2022.10.023_bb0010) 1990; 79
Nie (10.1016/j.jconrel.2022.10.023_bb0920) 2020; 160
Cherkasov (10.1016/j.jconrel.2022.10.023_bb0855) 2020; 103
Law (10.1016/j.jconrel.2022.10.023_bb1000) 2020; 48
Salvador-Morales (10.1016/j.jconrel.2022.10.023_bb0285) 2009; 30
Yang (10.1016/j.jconrel.2022.10.023_bb0190) 2010; 10
Traini (10.1016/j.jconrel.2022.10.023_bb1065) 2019; 15
Lisi (10.1016/j.jconrel.2022.10.023_bb1100) 2017; 645
Kamerkar (10.1016/j.jconrel.2022.10.023_bb0585) 2017; 546
Maziveyi (10.1016/j.jconrel.2022.10.023_bb0570) 2019; 79
Wen (10.1016/j.jconrel.2022.10.023_bb0620) 2022; 18
Ding (10.1016/j.jconrel.2022.10.023_bb0645) 2020; 7
Li (10.1016/j.jconrel.2022.10.023_bb0785) 2016; 140
Liu (10.1016/j.jconrel.2022.10.023_bb0745) 2013; 14
Cheng (10.1016/j.jconrel.2022.10.023_bb1195) 2018; 140
Zhang (10.1016/j.jconrel.2022.10.023_bb1010) 2021; 253
Gardner (10.1016/j.jconrel.2022.10.023_bb0595) 2021; 81
Yücel (10.1016/j.jconrel.2022.10.023_bb1005) 2020; 31
Kornfeld (10.1016/j.jconrel.2022.10.023_bb0385) 1987; 1
Gao (10.1016/j.jconrel.2022.10.023_bb0805) 2019; 174
Sobot (10.1016/j.jconrel.2022.10.023_bb0955) 2017; 25
Agarwal (10.1016/j.jconrel.2022.10.023_bb0080) 2016; 18
Peng (10.1016/j.jconrel.2022.10.023_bb0195) 2012; 12
Wang (10.1016/j.jconrel.2022.10.023_bb0680) 2019; 10
Ha (10.1016/j.jconrel.2022.10.023_bb0550) 2016; 6
Wu (10.1016/j.jconrel.2022.10.023_bb0555) 2020; 9
Chen (10.1016/j.jconrel.2022.10.023_bb0825) 2015; 27
Khanna (10.1016/j.jconrel.2022.10.023_bb0875) 2019; 1
Allen (10.1016/j.jconrel.2022.10.023_bb0020) 2002; 2
Partl (10.1016/j.jconrel.2022.10.023_bb0015) 2018; 194
Schmidts (10.1016/j.jconrel.2022.10.023_bb1190) 2018; 9
Sharma (10.1016/j.jconrel.2022.10.023_bb1030) 2015; 348
Noy (10.1016/j.jconrel.2022.10.023_bb1085) 2014; 41
Jin (10.1016/j.jconrel.2022.10.023_bb0965) 2017; 9
Ahmad (10.1016/j.jconrel.2022.10.023_bb0150) 2021; 2000
Liu (10.1016/j.jconrel.2022.10.023_bb0765) 2017; 9
Ulbrich (10.
References_xml – volume: 17
  year: 2019
  ident: bb0170
  article-title: A standardized citation metrics author database annotated for scientific field
  publication-title: PLoS Biol.
– volume: 142
  start-page: 1265
  year: 2020
  end-page: 1277
  ident: bb0925
  article-title: Precision-guided missile-like DNA nanostructure containing warhead and guidance control for Aptamer-based targeted drug delivery into cancer cells in vitro and in vivo
  publication-title: J. Am. Chem. Soc.
– volume: 83
  start-page: 28
  year: 2016
  end-page: 35
  ident: bb0890
  article-title: EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery
  publication-title: Eur. J. Pharm. Sci.
– volume: 29
  start-page: 692
  year: 2019
  end-page: 711
  ident: bb0115
  article-title: The top 100 most-cited papers in paediatric dentistry journals: a bibliometric analysis
  publication-title: Int. J. Paediatr. Dent.
– volume: 4
  start-page: 807
  year: 2022
  end-page: 819
  ident: bb0665
  article-title: Tumor-anchoring drug-loaded fibrous microspheres for MR imaging-guided local chemotherapy and metastasis inhibition
  publication-title: Adv. Fiber Mater.
– volume: 17
  start-page: 761
  year: 2018
  end-page: 772
  ident: bb1080
  article-title: Biomaterial-assisted targeted modulation of immune cells in cancer treatment
  publication-title: Nat. Mater.
– volume: 14
  start-page: 17365
  year: 2020
  end-page: 17375
  ident: bb0910
  article-title: Hierarchical fabrication of DNA wireframe Nanoarchitectures for efficient cancer imaging and targeted therapy
  publication-title: ACS Nano
– volume: 111
  start-page: 1103
  year: 2020
  end-page: 1112
  ident: bb1105
  article-title: Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
  publication-title: Cancer Sci.
– volume: 9
  start-page: 16365
  year: 2017
  end-page: 16374
  ident: bb0965
  article-title: EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy
  publication-title: Nanoscale.
– volume: 3
  start-page: 16
  year: 2009
  end-page: 20
  ident: bb0305
  article-title: Impact of nanotechnology on drug delivery
  publication-title: ACS Nano
– volume: 42
  start-page: 7289
  year: 2013
  end-page: 7325
  ident: bb0705
  article-title: Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance
  publication-title: Chem. Soc. Rev.
– volume: 114
  start-page: 206
  year: 2017
  end-page: 221
  ident: bb1135
  article-title: Progress in tumor-associated macrophage (TAM)-targeted therapeutics
  publication-title: Adv. Drug Deliv. Rev.
– volume: 13
  start-page: 240
  year: 2018
  ident: bb0025
  article-title: Modified Fe
  publication-title: Nanoscale Res. Lett.
– volume: 17
  start-page: 686
  year: 2018
  end-page: 697
  ident: bb1300
  article-title: Scavenger receptor type B1 and lipoprotein nanoparticle inhibit myeloid-derived suppressor cells
  publication-title: Mol. Cancer Ther.
– volume: 18
  start-page: 296
  year: 2016
  end-page: 309
  ident: bb0080
  article-title: Bibliometrics: tracking research impact by selecting the appropriate metrics
  publication-title: Asian J. Androl.
– volume: 110
  start-page: 406
  year: 2018
  end-page: 415
  ident: bb0880
  article-title: Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy
  publication-title: Int. J. Biol. Macromol.
– volume: 165
  start-page: 164
  year: 2021
  end-page: 173
  ident: bb1015
  article-title: Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression
  publication-title: Eur. J. Pharm. Biopharm.
– volume: 72
  start-page: 102
  year: 2014
  end-page: 107
  ident: bb0035
  article-title: Chemotherapy
  publication-title: Nihon Rinsho
– volume: 33
  start-page: 5776
  year: 2012
  end-page: 5787
  ident: bb1260
  article-title: Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
  publication-title: Biomaterials.
– volume: 5
  start-page: 161
  year: 2005
  end-page: 171
  ident: bb0045
  article-title: Cancer nanotechnology: opportunities and challenges
  publication-title: Nat. Rev. Cancer
– volume: 32
  year: 2020
  ident: bb0360
  article-title: A multistage cooperative Nanoplatform enables intracellular co-delivery of proteins and chemotherapeutics for cancer therapy
  publication-title: Adv. Mater.
– volume: 140
  start-page: 16413
  year: 2018
  end-page: 16417
  ident: bb1195
  article-title: Reprogramming exosomes as nanoscale controllers of cellular immunity
  publication-title: J. Am. Chem. Soc.
– volume: 339
  start-page: 114
  year: 2021
  end-page: 129
  ident: bb0615
  article-title: NIR-activated self-sensitized polymeric micelles for enhanced cancer chemo-photothermal therapy
  publication-title: J. Control. Release
– volume: 134
  start-page: 47
  year: 2015
  end-page: 58
  ident: bb0990
  article-title: Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin
  publication-title: Colloids Surf. B: Biointerfaces
– volume: 32
  year: 2020
  ident: bb0840
  article-title: Ligand-installed Nanocarriers toward precision therapy
  publication-title: Adv. Mater.
– volume: 3
  start-page: 1377
  year: 2011
  end-page: 1397
  ident: bb0260
  article-title: Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier
  publication-title: Polymers.
– volume: 12
  start-page: 813
  year: 2017
  end-page: 820
  ident: bb1185
  article-title: In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
  publication-title: Nat. Nanotechnol.
– volume: 1
  start-page: 480
  year: 2016
  end-page: 487
  ident: bb0640
  article-title: Redox stimuli-responsive hollow mesoporous silica nanocarriers for targeted drug delivery in cancer therapy
  publication-title: Nanosc. Horiz.
– volume: 57
  start-page: 359
  year: 2006
  end-page: 377
  ident: bb0165
  article-title: Detecting and visualizing emerging trends and transient patterns in scientific literature
  publication-title: J. Am. Soc. Inf. Sci. Technol.
– volume: 29
  start-page: 1805582
  year: 2018
  ident: bb0775
  article-title: Ultralong circulating lollipop-like nanoparticles assembled with gossypol, doxorubicin, and Polydopamine via π-π stacking for synergistic tumor therapy
  publication-title: Adv. Funct. Mater.
– volume: 143
  start-page: 1806
  year: 2018
  end-page: 1816
  ident: bb1165
  article-title: Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors
  publication-title: Int. J. Cancer
– volume: 143
  year: 2020
  ident: bb0155
  article-title: Co-authorship network analysis in cardiovascular research utilizing machine learning (2009-2019)
  publication-title: Int. J. Med. Inform.
– volume: 16
  start-page: 599
  year: 2016
  end-page: 611
  ident: bb1175
  article-title: Regulatory circuits of T cell function in cancer
  publication-title: Nat. Rev. Immunol.
– volume: 33
  start-page: 133
  year: 2018
  end-page: 145
  ident: bb1120
  article-title: The role of tumor-associated macrophage in breast cancer biology
  publication-title: Histol. Histopathol.
– volume: 15
  year: 2019
  ident: bb0945
  article-title: Direct nucleus-targeted drug delivery using cascade pH
  publication-title: Small.
– volume: 63
  start-page: 1996024
  year: 2019
  ident: bb0770
  article-title: Amphiphilic drug-drug conjugate for cancer therapy with combination of chemotherapeutic and antiangiogenesis drugs
  publication-title: Sci. China Chem.
– volume: 13
  year: 2017
  ident: bb1270
  article-title: Inhibiting solid tumor growth in vivo by non-tumor-penetrating nanomedicine
  publication-title: Small.
– volume: 6
  start-page: 287
  year: 2016
  end-page: 296
  ident: bb0550
  article-title: Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
  publication-title: Acta Pharm. Sin. B
– volume: 141
  start-page: 20354
  year: 2019
  end-page: 20364
  ident: bb0905
  article-title: Programming drug delivery kinetics for active burst release with DNA toehold switches
  publication-title: J. Am. Chem. Soc.
– volume: 20
  start-page: 3039
  year: 2020
  end-page: 3049
  ident: bb0800
  article-title: Photoactivatable prodrug-backboned polymeric nanoparticles for efficient light-controlled gene delivery and synergistic treatment of platinum-resistant ovarian cancer
  publication-title: Nano Lett.
– volume: 122
  start-page: 31
  year: 2017
  end-page: 64
  ident: bb0100
  article-title: Nanoparticles for drug delivery to the anterior segment of the eye
  publication-title: Adv. Drug Deliv. Rev.
– volume: 8
  start-page: 32688
  year: 2016
  end-page: 32698
  ident: bb0635
  article-title: A protein-polymer bioconjugate-coated upconversion nanosystem for simultaneous tumor cell imaging, photodynamic therapy, and chemotherapy
  publication-title: ACS Appl. Mater. Interfaces
– volume: 4
  year: 2018
  ident: bb0160
  article-title: Document co-citation analysis to enhance transdisciplinary research
  publication-title: Sci. Adv.
– volume: 91
  start-page: 2610
  year: 2019
  end-page: 2614
  ident: bb0900
  article-title: Programmable self-assembly of protein-Scaffolded DNA Nanohydrogels for tumor-targeted imaging and therapy
  publication-title: Anal. Chem.
– volume: 65
  start-page: 1
  year: 2013
  end-page: 14
  ident: bb0700
  article-title: Prodrugs: a challenge for the drug development
  publication-title: Pharmacol. Rep.
– volume: 14
  start-page: 14164
  year: 2020
  end-page: 14180
  ident: bb0520
  article-title: Engineering of cascade-responsive nanoplatform to inhibit lactate efflux for enhanced tumor chemo-immunotherapy
  publication-title: ACS Nano
– volume: 12
  start-page: 4271
  year: 2012
  end-page: 4275
  ident: bb0220
  article-title: Negligible particle-specific antibacterial activity of silver nanoparticles
  publication-title: Nano Lett.
– volume: 608
  year: 2021
  ident: bb0105
  article-title: Advances and challenges in the nanoparticles-laden contact lenses for ocular drug delivery
  publication-title: Int. J. Pharm.
– volume: 7
  start-page: 6782
  year: 2013
  end-page: 6795
  ident: bb0330
  article-title: Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect
  publication-title: ACS Nano
– volume: 15
  start-page: 138
  year: 2019
  end-page: 150
  ident: bb1170
  article-title: Multiwalled carbon nanotubes prevent tumor metastasis through switching M2-polarized macrophages to M1 via TLR4 activation
  publication-title: J. Biomed. Nanotechnol.
– volume: 14
  start-page: 17
  year: 2018
  end-page: 32
  ident: bb0885
  article-title: PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells
  publication-title: Int. J. Nanomedicine
– volume: 12
  start-page: 844
  year: 2012
  end-page: 849
  ident: bb0195
  article-title: Graphene quantum dots derived from carbon fibers
  publication-title: Nano Lett.
– volume: 21
  start-page: 921
  year: 2020
  end-page: 929
  ident: bb0735
  article-title: Glutathione and reactive oxygen species dual-responsive block copolymer prodrugs for boosting tumor site-specific drug release and enhanced antitumor efficacy
  publication-title: Biomacromolecules.
– volume: 294
  start-page: 376
  year: 2018
  end-page: 389
  ident: bb0755
  article-title: Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy
  publication-title: J. Control. Release
– volume: 13
  start-page: 525
  year: 2013
  end-page: 541
  ident: bb1025
  article-title: Gene-engineered T cells for cancer therapy
  publication-title: Nat. Rev. Cancer
– volume: 7
  start-page: 773
  year: 2019
  end-page: 788
  ident: bb1245
  article-title: In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles
  publication-title: Biomater. Sci.
– volume: 7
  start-page: 13193
  year: 2016
  ident: bb1055
  article-title: Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
  publication-title: Nat. Commun.
– volume: 15
  start-page: 2439
  year: 2020
  end-page: 2483
  ident: bb0530
  article-title: Novel drug delivery systems for loading of natural plant extracts and their biomedical applications
  publication-title: Int. J. Nanomedicine
– volume: 348
  start-page: 56
  year: 2015
  end-page: 61
  ident: bb1030
  article-title: The future of immune checkpoint therapy
  publication-title: Science.
– volume: 104
  start-page: 2050
  year: 2007
  end-page: 2055
  ident: bb0280
  article-title: Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 30
  start-page: 2005918
  year: 2020
  ident: bb0750
  article-title: ROS-responsive camptothecin prodrug nanoparticles for on-demand drug release and combination of chemotherapy and photodynamic therapy
  publication-title: Adv. Funct. Mater.
– volume: 103
  start-page: 223
  year: 2020
  end-page: 236
  ident: bb0855
  article-title: Antibody-directed metal-organic framework nanoparticles for targeted drug delivery
  publication-title: Acta Biomater.
– volume: 15
  year: 2019
  ident: bb1065
  article-title: Cancer immunotherapy of TLR4 agonist-antigen constructs enhanced with pathogen-mimicking magnetite nanoparticles and checkpoint blockade of PD-L1
  publication-title: Small.
– volume: 1223
  start-page: 155
  year: 2020
  end-page: 165
  ident: bb1095
  article-title: CD200-CD200R pathway in the regulation of tumor immune microenvironment and immunotherapy
  publication-title: Adv. Exp. Med. Biol.
– volume: 130
  start-page: 2382
  year: 2008
  end-page: 2383
  ident: bb0315
  article-title: Enzyme-responsive snap-top covered silica nanocontainers
  publication-title: J. Am. Chem. Soc.
– volume: 48
  start-page: 542
  year: 2020
  end-page: 559
  ident: bb1000
  article-title: Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models
  publication-title: Artif. Cells Nanomed. Biotechnol.
– volume: 82
  start-page: 545
  year: 2012
  end-page: 553
  ident: bb0540
  article-title: Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation
  publication-title: Eur. J. Pharm. Biopharm.
– volume: 9
  start-page: 1015
  year: 2019
  end-page: 1028
  ident: bb0590
  article-title: Design strategies and application progress of therapeutic exosomes
  publication-title: Theranostics.
– volume: 6
  start-page: 470
  year: 2016
  end-page: 484
  ident: bb0895
  article-title: Polydopamine-based surface modification of novel nanoparticle-Aptamer bioconjugates for in vivo breast cancer targeting and enhanced therapeutic effects
  publication-title: Theranostics.
– volume: 98
  year: 2019
  ident: bb0110
  article-title: Top-100 highest-cited original articles in inflammatory bowel disease: a bibliometric analysis
  publication-title: Medicine.
– volume: 21
  start-page: 202
  year: 2020
  ident: bb0915
  article-title: Targeted delivery of doxorubicin liposomes for her-2+ breast cancer treatment
  publication-title: AAPS PharmSciTech
– volume: 46
  start-page: 3830
  year: 2017
  end-page: 3852
  ident: bb0355
  article-title: Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumor microenvironment
  publication-title: Chem. Soc. Rev.
– volume: 8
  start-page: 10726
  year: 2016
  end-page: 10736
  ident: bb0930
  article-title: cRGD-modified benzimidazole-based pH-responsive nanoparticles for enhanced tumor targeted doxorubicin delivery
  publication-title: ACS Appl. Mater. Interfaces
– volume: 84
  start-page: 523
  year: 2010
  end-page: 538
  ident: bb0085
  article-title: Software survey: VOSviewer, a computer program for bibliometric mapping
  publication-title: Scientometrics
– volume: 22
  year: 2021
  ident: bb0405
  article-title: The international society of RNA nanotechnology and Nanomedicine (ISRNN): the present and future of the burgeoning field
  publication-title: ACS Nano
– volume: 96
  start-page: 456
  year: 2019
  end-page: 467
  ident: bb0605
  article-title: Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency
  publication-title: Acta Biomater.
– volume: 6
  year: 2011
  ident: bb0240
  article-title: Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo
  publication-title: PLoS One
– volume: 33
  year: 2021
  ident: bb0670
  article-title: Supramolecular nanofibrils formed by coassembly of clinically approved drugs for tumor photothermal immunotherapy
  publication-title: Adv. Mater.
– volume: 8
  start-page: 329
  year: 2018
  end-page: 341
  ident: bb0510
  article-title: Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer
  publication-title: Drug Deliv. Transl. Res.
– volume: 173
  start-page: 57
  year: 2017
  end-page: 66
  ident: bb0820
  article-title: Multiple polysaccharide-drug complex-loaded liposomes: a unique strategy in drug loading and cancer targeting
  publication-title: Carbohydr. Polym.
– volume: 3
  start-page: 279
  year: 2009
  end-page: 290
  ident: bb0185
  article-title: Cytotoxicity and genotoxicity of silver nanoparticles in human cells
  publication-title: ACS Nano
– volume: 8
  year: 2021
  ident: bb0410
  article-title: Nanotechnology for targeted detection and removal of bacteria: opportunities and challenges
  publication-title: Adv. Sci.
– volume: 1
  start-page: FDD8
  year: 2019
  ident: bb0875
  article-title: Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
  publication-title: Future Drug Discov.
– volume: 16
  start-page: 5401
  year: 2016
  end-page: 5408
  ident: bb0760
  article-title: Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy
  publication-title: Nano Lett.
– volume: 137
  start-page: 6112
  year: 2015
  end-page: 6115
  ident: bb0830
  article-title: Light-triggered, self-Immolative nucleic acid-drug nanostructures
  publication-title: J. Am. Chem. Soc.
– volume: 14
  start-page: 1627
  year: 2013
  end-page: 1636
  ident: bb0745
  article-title: Therapeutic nanocarriers with hydrogen peroxide-triggered drug release for cancer treatment
  publication-title: Biomacromolecules.
– volume: 53
  start-page: 8596
  year: 2017
  end-page: 8599
  ident: bb0980
  article-title: GSH-responsive supramolecular nanoparticles constructed by β-d-galactose-modified pillar[5]arene and camptothecin prodrug for targeted anticancer drug delivery
  publication-title: Chem. Commun.
– volume: 10
  start-page: 3318
  year: 2010
  end-page: 3323
  ident: bb0190
  article-title: Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy
  publication-title: Nano Lett.
– volume: 10
  start-page: 36862
  year: 2020
  end-page: 36872
  ident: bb0515
  article-title: Functionalization of MOF-5 with mono-substituents: effects on drug delivery behavior
  publication-title: RSC Adv.
– volume: 350
  start-page: 122
  year: 2022
  end-page: 131
  ident: bb0610
  article-title: Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapy
  publication-title: J. Control. Release
– volume: 10
  start-page: 8956
  year: 2016
  end-page: 8963
  ident: bb1315
  article-title: Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors
  publication-title: ACS Nano
– volume: 111
  year: 2020
  ident: bb0470
  article-title: Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles
  publication-title: Mater. Sci. Eng. C Mater. Biol. Appl.
– volume: 15
  start-page: 220
  year: 2020
  ident: bb0870
  article-title: hGC33-modified and Sorafenib-loaded nanoparticles have a synergistic anti-Hepatoma effect by inhibiting Wnt Signaling pathway
  publication-title: Nanoscale Res. Lett.
– volume: 12
  start-page: 2673
  year: 2020
  end-page: 2685
  ident: bb1320
  article-title: Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release
  publication-title: Nanoscale.
– volume: 10
  start-page: 767
  year: 2011
  end-page: 777
  ident: bb0350
  article-title: Interfering with pH regulation in tumours as a therapeutic strategy
  publication-title: Nat. Rev. Drug Discov.
– volume: 28
  start-page: 4440
  year: 2016
  end-page: 4446
  ident: bb0740
  article-title: Redox-hypersensitive organic nanoparticles for selective treatment of cancer cells
  publication-title: Chem. Mater.
– volume: 413
  start-page: 36
  year: 2001
  end-page: 37
  ident: bb0250
  article-title: Immune recognition. A new receptor for beta-glucans
  publication-title: Nature.
– volume: 31
  start-page: 359
  year: 2006
  end-page: 397
  ident: bb0695
  article-title: Polymer-drug conjugates: progress in polymeric prodrugs
  publication-title: Prog. Polym. Sci.
– volume: 13
  start-page: 3821
  year: 2022
  ident: bb0630
  article-title: An in situ hydrogel-mediated chemo-immunometabolic cancer therapy
  publication-title: Nat. Commun.
– volume: 307
  start-page: 1630
  year: 2005
  end-page: 1634
  ident: bb1040
  article-title: Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate
  publication-title: Science.
– volume: 4
  start-page: 148rv9
  year: 2012
  ident: bb0060
  article-title: Engineering approaches to immunotherapy
  publication-title: Sci. Transl. Med.
– volume: 21
  start-page: 9123
  year: 2020
  ident: bb0845
  article-title: Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy
  publication-title: Int. J. Mol. Sci.
– volume: 46
  start-page: 28
  year: 2018
  end-page: 37
  ident: bb0525
  article-title: pH-sensitive and biocompatible quercetin-loaded GO-PEA-HA carrier improved antitumour efficiency and specificity
  publication-title: Artif. Cells Nanomed. Biotechnol.
– volume: 166
  start-page: 13
  year: 2018
  end-page: 26
  ident: bb0245
  article-title: Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery
  publication-title: Biomaterials.
– volume: 14
  start-page: 1295
  year: 2014
  end-page: 1317
  ident: bb0130
  article-title: Emerging trends and new developments in regenerative medicine: a scientometric update (2000–2014)
  publication-title: Expert. Opin. Biol. Ther.
– volume: 31
  year: 2020
  ident: bb1005
  article-title: Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells
  publication-title: Nanotechnology.
– volume: 252
  year: 2021
  ident: bb0600
  article-title: Pectin co-functionalized dual layered solid lipid nanoparticle made by soluble curcumin for the targeted potential treatment of colorectal cancer
  publication-title: Carbohydr. Polym.
– volume: 56
  start-page: 8861
  year: 2020
  end-page: 8864
  ident: bb0815
  article-title: Supramolecular nanoprodrug based on boronate ester linked curcumin complexing with water-soluble pillar[5]arene for synergistic chemotherapies
  publication-title: Chem. Commun. (Camb.)
– volume: 2000
  start-page: 237
  year: 2021
  end-page: 240
  ident: bb0150
  article-title: A bibliometric analysis of periodontology
  publication-title: Periodontol
– volume: 12
  start-page: 151
  year: 2020
  end-page: 162
  ident: bb0430
  article-title: PEGylation of paclitaxel-loaded cationic liposomes drives steric stabilization of Bicelles and vesicles thereby enhancing delivery and cytotoxicity to human cancer cells
  publication-title: ACS Appl. Mater. Interfaces
– volume: 79
  start-page: 949
  year: 1990
  end-page: 962
  ident: bb0010
  article-title: Drug targeting in cancer chemotherapy: a clinical perspective
  publication-title: J. Pharm. Sci.
– volume: 14
  start-page: 4890
  year: 2020
  end-page: 4904
  ident: bb0795
  article-title: Enzyme-triggered Transcytosis of dendrimer-drug conjugate for deep penetration into pancreatic Tumors
  publication-title: ACS Nano
– volume: 66
  start-page: 8927
  year: 2006
  end-page: 8930
  ident: bb0340
  article-title: Cancer’s molecular sweet tooth and the Warburg effect
  publication-title: Cancer Res.
– volume: 29
  start-page: 4828
  year: 2011
  end-page: 4836
  ident: bb1020
  article-title: Cancer immunotherapy comes of age
  publication-title: J. Clin. Oncol.
– volume: 31
  year: 2019
  ident: bb1150
  article-title: Tailoring nanomaterials for targeting tumor-associated macrophages
  publication-title: Adv. Mater.
– volume: 2
  start-page: 750
  year: 2002
  end-page: 763
  ident: bb0020
  article-title: Ligand-targeted therapeutics in anticancer therapy
  publication-title: Nat. Rev. Cancer
– volume: 577
  start-page: 549
  year: 2020
  end-page: 555
  ident: bb1225
  article-title: B cells and tertiary lymphoid structures promote immunotherapy response
  publication-title: Nature.
– volume: 41
  start-page: 2590
  year: 2012
  end-page: 2605
  ident: bb0270
  article-title: ChemInform abstract: mesoporous silica nanoparticles in biomedical applications
  publication-title: Chem. Soc. Rev.
– volume: 11
  start-page: 594
  year: 2020
  ident: bb0970
  article-title: Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
  publication-title: Nat. Commun.
– volume: 10
  start-page: 2778
  year: 2019
  end-page: 2784
  ident: bb1325
  article-title: Carrier-free nano-integrated strategy for synergetic cancer anti-angiogenic therapy and phototherapy
  publication-title: Chem. Sci.
– volume: 71
  start-page: 3364
  year: 2011
  end-page: 3376
  ident: bb0235
  article-title: Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
  publication-title: Cancer Res.
– volume: 359
  start-page: 1037
  year: 2018
  end-page: 1042
  ident: bb1220
  article-title: Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
  publication-title: Science.
– volume: 31
  start-page: 2004500
  year: 2020
  ident: bb0950
  article-title: Pulmonary targeting crosslinked cyclodextrin metal–organic frameworks for lung cancer therapy
  publication-title: Adv. Funct. Mater.
– volume: 193
  start-page: 153
  year: 2018
  end-page: 162
  ident: bb0790
  article-title: Reduction-active polymeric prodrug micelles based on α-cyclodextrin polyrotaxanes for triggered drug release and enhanced cancer therapy
  publication-title: Carbohydr. Polym.
– volume: 17
  start-page: 3282
  year: 2017
  end-page: 3289
  ident: bb0320
  article-title: Bioresponsive polyoxometalate cluster for redox-activated photoacoustic imaging-guided photothermal cancer therapy
  publication-title: Nano Lett.
– volume: 603
  year: 2020
  ident: bb0275
  article-title: Iron oxide @ gold nanoparticles: synthesis, properties and potential use as anode materials for lithium-ion batteries
  publication-title: Colloids Surf. A Physicochem. Eng. Asp.
– volume: 18
  start-page: 3571
  year: 2018
  end-page: 3579
  ident: bb1290
  article-title: Repolarization of tumor-associated macrophages in a genetically engineered nonsmall cell lung cancer model by intraperitoneal administration of hyaluronic acid-based nanoparticles encapsulating MicroRNA-125b
  publication-title: Nano Lett.
– volume: 546
  start-page: 498
  year: 2017
  end-page: 503
  ident: bb0585
  article-title: Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
  publication-title: Nature.
– volume: 27
  start-page: 903
  year: 2015
  end-page: 910
  ident: bb0825
  article-title: An Imagable and Photothermal “Abraxane-like” Nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast Tumors
  publication-title: Adv. Mater.
– volume: 3
  start-page: 1598
  year: 2020
  end-page: 1606
  ident: bb0495
  article-title: Glucose and H
  publication-title: ACS Appl. Bio Mater.
– volume: 234
  start-page: 8509
  year: 2019
  end-page: 8521
  ident: bb1130
  article-title: CD8
  publication-title: J. Cell. Physiol.
– volume: 8
  start-page: 6765
  year: 2020
  end-page: 6781
  ident: bb1330
  article-title: Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy
  publication-title: J. Mater. Chem. B
– volume: 66
  start-page: 2
  year: 2014
  end-page: 25
  ident: bb0290
  article-title: Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology
  publication-title: Adv. Drug Deliv. Rev.
– volume: 13
  start-page: 957
  year: 2018
  end-page: 973
  ident: bb1250
  article-title: Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles
  publication-title: Int. J. Nanomedicine
– volume: 30
  start-page: 2003757
  year: 2020
  ident: bb0390
  article-title: pH/Cathepsin B hierarchical-responsive nanoconjugates for enhanced tumor penetration and chemo-immunotherapy
  publication-title: Adv. Funct. Mater.
– volume: 9
  start-page: 29496
  year: 2017
  end-page: 29504
  ident: bb0765
  article-title: GSH-activatable NIR fluorescent prodrug for podophyllotoxin delivery
  publication-title: ACS Appl. Mater. Interfaces
– volume: 13
  start-page: 3083
  year: 2019
  end-page: 3094
  ident: bb1235
  article-title: In situ dendritic cell vaccine for effective cancer immunotherapy
  publication-title: ACS Nano
– volume: 27
  start-page: 3944
  year: 2020
  end-page: 3966
  ident: bb1145
  article-title: Small-molecule CSF1R inhibitors as anticancer agents
  publication-title: Curr. Med. Chem.
– volume: 30
  start-page: 1905758
  year: 2020
  ident: bb0365
  article-title: NIR/ROS in esponsive black phosphorus QD vesicles as Immunoadjuvant carrier for specific cancer photodynamic immunotherapy
  publication-title: Adv. Funct. Mater.
– volume: 624
  start-page: 25
  year: 2010
  end-page: 37
  ident: bb0425
  article-title: Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting
  publication-title: Methods Mol. Biol.
– volume: 538
  start-page: 630
  year: 2019
  end-page: 637
  ident: bb0860
  article-title: Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer
  publication-title: J. Colloid Interface Sci.
– volume: 31
  year: 2019
  ident: bb1070
  article-title: Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy
  publication-title: Adv. Mater.
– volume: 213
  year: 2015
  ident: bb0725
  article-title: Glycyrrhetinic acid-decorated and reduction-sensitive micelles for targeted cancer therapy
  publication-title: J. Control. Release
– volume: 25
  start-page: 1596
  year: 2017
  end-page: 1605
  ident: bb0955
  article-title: Circulating lipoproteins: a Trojan horse guiding squalenoylated drugs to LDL-accumulating cancer cells
  publication-title: Mol. Ther.
– volume: 14
  year: 2013
  ident: bb0070
  article-title: Big moment for nanotech: oncology therapeutics poised for a leap
  publication-title: OncLive
– volume: 26
  start-page: 1
  year: 2019
  end-page: 11
  ident: bb0985
  article-title: Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
  publication-title: Drug Deliv.
– volume: 29
  start-page: 1902440
  year: 2019
  ident: bb1060
  article-title: Hyaluronidase with Ph-responsive dextran modification as an adjuvant nanomedicine for enhanced photodynamic-immunotherapy of cancer
  publication-title: Adv. Funct. Mater.
– volume: 69
  start-page: 351
  year: 2019
  end-page: 362
  ident: bb0005
  article-title: The American Cancer Society 2035 challenge goal on cancer mortality reduction
  publication-title: CA Cancer J. Clin.
– volume: 11
  start-page: 2396
  year: 2021
  end-page: 2415
  ident: bb0715
  article-title: A review of existing strategies for designing long-acting parenteral formulations: focus on underlying mechanisms, and future perspectives
  publication-title: Acta Pharm. Sin. B
– volume: 47
  start-page: 2084
  year: 2014
  end-page: 2095
  ident: bb0710
  article-title: Engineering responsive polymer building blocks with host-guest molecular recognition for functional applications
  publication-title: Acc. Chem. Res.
– volume: 24
  start-page: 852
  year: 2013
  end-page: 858
  ident: bb1295
  article-title: In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes
  publication-title: Bioconjug. Chem.
– volume: 5
  start-page: 275
  year: 2005
  end-page: 284
  ident: bb0230
  article-title: Tumour stem cells and drug resistance
  publication-title: Nat. Rev. Cancer
– volume: 27
  start-page: 1482
  year: 2016
  end-page: 1492
  ident: bb1205
  article-title: Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
  publication-title: Ann. Oncol.
– volume: 367
  start-page: eaau6977
  year: 2020
  ident: bb0545
  article-title: The biology, function, and biomedical applications of exosomes
  publication-title: Science.
– volume: 556
  start-page: 217
  year: 2019
  end-page: 225
  ident: bb0935
  article-title: RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability
  publication-title: Int. J. Pharm.
– volume: 139
  start-page: 91
  year: 2019
  end-page: 105
  ident: bb0030
  article-title: Curcumin in combination with anti-cancer drugs: a nanomedicine review
  publication-title: Pharmacol. Res.
– volume: 10
  start-page: 451
  year: 2015
  end-page: 467
  ident: bb0380
  article-title: Photoresponsive nanoparticles for drug delivery
  publication-title: Nano Today
– volume: 329
  start-page: 645
  year: 2021
  end-page: 664
  ident: bb1155
  article-title: Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages
  publication-title: J. Control. Release
– volume: 101
  start-page: 5303
  year: 2004
  end-page: 5310
  ident: bb0140
  article-title: Searching for intellectual turning points: progressive knowledge domain visualization
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 46
  start-page: 1095
  year: 2018
  end-page: 1110
  ident: bb0500
  article-title: Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment
  publication-title: Artif. Cells Nanomed. Biotechnol.
– volume: 116
  start-page: 5338
  year: 2016
  end-page: 5431
  ident: bb0075
  article-title: Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies
  publication-title: Chem. Rev.
– volume: 86
  start-page: 589
  year: 2015
  end-page: 598
  ident: bb0400
  article-title: Synthesis and evaluation of a CBZ-AAN-dox prodrug and its in vitro effects on SiHa cervical cancer cells under hypoxic conditions
  publication-title: Chem. Biol. Drug Des.
– volume: 11
  start-page: 2226
  year: 2021
  end-page: 2234
  ident: bb0445
  article-title: Implementation of the emulsification-diffusion method by solvent displacement for polystyrene nanoparticles prepared from recycled material
  publication-title: RSC Adv.
– volume: 577
  start-page: 561
  year: 2020
  end-page: 565
  ident: bb1230
  article-title: Tertiary lymphoid structures improve immunotherapy and survival in melanoma
  publication-title: Nature.
– volume: 11
  start-page: 13078
  year: 2019
  end-page: 13088
  ident: bb0730
  article-title: Enhancement of ultralow-intensity NIR light-triggered photodynamic therapy based on exo- and endogenous synergistic effects through combined glutathione-depletion chemotherapy
  publication-title: Nanoscale.
– volume: 148
  start-page: 135
  year: 2010
  end-page: 146
  ident: bb0835
  article-title: To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
  publication-title: J. Control. Release
– volume: 16
  start-page: 193
  year: 2016
  end-page: 201
  ident: bb1180
  article-title: T cell migration, search strategies and mechanisms
  publication-title: Nat. Rev. Immunol.
– volume: 12
  year: 2021
  ident: bb0145
  article-title: Bibliometric analysis of global research trends on ultrasound microbubble: a quickly developing field
  publication-title: Front. Pharmacol.
– volume: 9
  start-page: 101
  year: 2010
  end-page: 113
  ident: bb0325
  article-title: Emerging applications of stimuli-responsive polymer materials
  publication-title: Nat. Mater.
– volume: 10
  start-page: 3838
  year: 2019
  ident: bb0690
  article-title: Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
  publication-title: Nat. Commun.
– volume: 58
  start-page: 14134
  year: 2019
  end-page: 14139
  ident: bb0370
  article-title: Programmed release of dihydroartemisinin for synergistic cancer therapy using a CaCO
  publication-title: Angew. Chem. Int. Ed. Eng.
– volume: 611
  year: 2021
  ident: bb0960
  article-title: Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells
  publication-title: Colloids Surf. A Physicochem. Eng. Asp.
– volume: 4
  start-page: 195
  year: 2020
  end-page: 206
  ident: bb1210
  article-title: Nitinol thin films functionalized with CAR-T cells for the treatment of solid tumours
  publication-title: Nat. Biomed. Eng.
– volume: 17
  start-page: 20
  year: 2017
  end-page: 37
  ident: bb0415
  article-title: Cancer nanomedicine: progress, challenges and opportunities
  publication-title: Nat. Rev. Cancer
– volume: 7
  start-page: 352
  year: 2022
  end-page: 367
  ident: bb0565
  article-title: Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment
  publication-title: Nanosc. Horiz.
– volume: 11
  start-page: 108
  year: 2021
  end-page: 121
  ident: bb0660
  article-title: Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines
  publication-title: J. Pharm. Biomed.
– volume: 1
  start-page: 203
  year: 2008
  end-page: 212
  ident: bb0180
  article-title: Nano-graphene oxide for cellular imaging and drug delivery
  publication-title: Nano Res.
– volume: 146
  start-page: 660
  year: 2019
  end-page: 670
  ident: bb0655
  article-title: Erythrocyte membrane camouflaged graphene oxide for tumor-targeted photothermal-chemotherapy
  publication-title: Carbon.
– volume: 34
  start-page: 571
  year: 2013
  end-page: 581
  ident: bb0335
  article-title: Multifunctional Fe3O4@C@ag hybrid nanoparticles as dual modal imaging probes and near-infrared light-responsive drug delivery platform
  publication-title: Biomaterials.
– volume: 253
  year: 2021
  ident: bb1010
  article-title: Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma
  publication-title: Carbohydr. Polym.
– volume: 13
  start-page: 1831
  year: 2018
  end-page: 1840
  ident: bb0850
  article-title: Trastuzumab- and fab’ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
  publication-title: Int. J. Nanomedicine
– volume: 5
  start-page: 829
  year: 2005
  end-page: 834
  ident: bb0200
  article-title: Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer
  publication-title: Nano Lett.
– volume: 44
  start-page: 1123
  year: 2011
  end-page: 1134
  ident: bb0300
  article-title: Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation
  publication-title: Acc. Chem. Res.
– volume: 79
  start-page: 2152
  year: 2019
  end-page: 2166
  ident: bb0570
  article-title: Exosomes from Nischarin-expressing cells reduce breast cancer cell motility and tumor growth
  publication-title: Cancer Res.
– volume: 25
  start-page: 268
  year: 2013
  end-page: 276
  ident: bb1200
  article-title: Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
  publication-title: Curr. Opin. Immunol.
– volume: 13
  start-page: 1164
  year: 2021
  ident: bb0460
  article-title: Stimuli-responsive hydrogels for cancer treatment: the role of pH, light, ionic strength and magnetic field
  publication-title: Cancers
– volume: 7
  start-page: 2001060
  year: 2020
  ident: bb0645
  article-title: A nanomedicine fabricated from gold nanoparticles-decorated metal-organic framework for cascade chemo/chemodynamic cancer therapy
  publication-title: Adv. Sci. (Weinh.)
– volume: 133
  start-page: 6825
  year: 2011
  end-page: 6831
  ident: bb0205
  article-title: Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy
  publication-title: J. Am. Chem. Soc.
– volume: 30
  start-page: 2231
  year: 2009
  end-page: 2240
  ident: bb0285
  article-title: Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups
  publication-title: Biomaterials.
– volume: 160
  year: 2020
  ident: bb0920
  article-title: Synthesis of Aptamer-PEI-g-PEG modified gold nanoparticles loaded with doxorubicin for targeted drug delivery
  publication-title: J. Vis. Exp.
– volume: 13
  start-page: 3256
  year: 2021
  ident: bb0265
  article-title: Chitosan: an overview of its properties and applications
  publication-title: Polymers.
– volume: 13
  start-page: 10939
  year: 2019
  end-page: 10960
  ident: bb0480
  article-title: Mucosal immunization with a pH-responsive nanoparticle vaccine induces protective CD8
  publication-title: ACS Nano
– volume: 14
  start-page: 14919
  year: 2020
  end-page: 14928
  ident: bb0455
  article-title: Ultrastable AgBiS
  publication-title: ACS Nano
– volume: 174
  start-page: 416
  year: 2019
  end-page: 425
  ident: bb0805
  article-title: Ultrasound triggered phase-change nanodroplets for doxorubicin prodrug delivery and ultrasound diagnosis: an in vitro study
  publication-title: Colloids Surf. B: Biointerfaces
– volume: 33
  start-page: 3235
  year: 2012
  end-page: 3242
  ident: bb0675
  article-title: Antitumor immunologically modified carbon nanotubes for photothermal therapy
  publication-title: Biomaterials.
– volume: 9
  start-page: 2593
  year: 2018
  ident: bb1190
  article-title: Making CAR T cells a solid option for solid Tumors
  publication-title: Front. Immunol.
– volume: 194
  start-page: 1060
  year: 2018
  end-page: 1065
  ident: bb0015
  article-title: Radiation-induced morphea-a rare but severe late effect of adjuvant breast irradiation: case report and review of the literature
  publication-title: Strahlenther. Onkol.
– volume: 10
  start-page: 257
  year: 2014
  end-page: 270
  ident: bb0435
  article-title: Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer
  publication-title: Int. J. Nanomedicine
– volume: 64
  start-page: 1005
  year: 2012
  end-page: 1020
  ident: bb0375
  article-title: Photochemical mechanisms of light-triggered release from nanocarriers
  publication-title: Adv. Drug Deliv. Rev.
– volume: 140
  start-page: 11
  year: 2016
  end-page: 18
  ident: bb0785
  article-title: Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery
  publication-title: Colloids Surf. B: Biointerfaces
– volume: 91
  start-page: 3
  year: 2015
  end-page: 6
  ident: bb0295
  article-title: Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
  publication-title: Adv. Drug Deliv. Rev.
– volume: 14
  start-page: 2181
  year: 2014
  end-page: 2188
  ident: bb1075
  article-title: Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery
  publication-title: Nano Lett.
– volume: 63
  start-page: 2957
  year: 2003
  end-page: 2964
  ident: bb0395
  article-title: Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy
  publication-title: Cancer Res.
– volume: 195
  start-page: 206
  year: 2012
  end-page: 214
  ident: bb0535
  article-title: Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat
  publication-title: Chem. Biol. Interact.
– volume: 8
  start-page: 137
  year: 2013
  end-page: 143
  ident: bb0225
  article-title: Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
  publication-title: Nat. Nanotechnol.
– volume: 29
  start-page: 1808646
  year: 2019
  ident: bb0780
  article-title: Poly (ferulic acid) with an anticancer effect as a drug nanocarrier for enhanced colon cancer therapy
  publication-title: Adv. Funct. Mater.
– volume: 17
  start-page: 528
  year: 2018
  end-page: 534
  ident: bb1240
  article-title: A facile approach to enhance antigen response for personalized cancer vaccination
  publication-title: Nat. Mater.
– volume: 29
  year: 2019
  ident: bb0650
  article-title: Cancer stem cell-platelet hybrid membrane-coated magnetic nanoparticles for enhanced photothermal therapy of head and neck squamous cell carcinoma
  publication-title: Adv. Funct.
– volume: 337
  start-page: 179
  year: 2021
  end-page: 192
  ident: bb0625
  article-title: Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma
  publication-title: J. Control. Release
– volume: 28
  start-page: 15906
  year: 2017
  ident: bb0810
  article-title: Nano-palladium is a cellular catalyst for in vivo chemistry
  publication-title: Nat. Commun.
– volume: 86
  start-page: 395
  year: 2019
  end-page: 405
  ident: bb0865
  article-title: Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
  publication-title: Acta Biomater.
– volume: 15
  start-page: 3640
  year: 2014
  end-page: 3659
  ident: bb0255
  article-title: An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering
  publication-title: Int. J. Mol. Sci.
– volume: 18
  start-page: 242
  year: 2022
  end-page: 253
  ident: bb0620
  article-title: On-demand assembly of polymeric nanoparticles for longer-blood-circulation and disassembly in tumor for boosting sonodynamic therapy
  publication-title: Bioact. Mater.
– volume: 8
  start-page: 816
  year: 2020
  ident: bb0125
  article-title: A bibliometric analysis using VOSviewer of publications on COVID-19
  publication-title: Ann. Transl. Med.
– volume: 13
  start-page: 1743
  year: 2016
  end-page: 1757
  ident: bb0095
  article-title: Application of lipid nanoparticles to ocular drug delivery
  publication-title: Expert. Opin. Drug Deliv.
– volume: 328
  start-page: 65
  year: 2013
  end-page: 76
  ident: bb1090
  article-title: The role of CD200-CD200R in tumor immune evasion
  publication-title: J. Theor. Biol.
– volume: 12
  start-page: 1004
  year: 2013
  end-page: 1017
  ident: bb0065
  article-title: Macroscale delivery systems for molecular and cellular payloads
  publication-title: Nat. Mater.
– volume: 10
  start-page: 10636
  year: 2016
  end-page: 10651
  ident: bb1285
  article-title: Gold nanoparticle reprograms pancreatic tumor microenvironment and inhibits tumor growth
  publication-title: ACS Nano
– volume: 9
  start-page: 3637
  year: 2017
  end-page: 3645
  ident: bb1035
  article-title: MRI-guided and ultrasound-triggered release of NO by advanced nanomedicine
  publication-title: Nanoscale.
– volume: 724–728
  year: 2005
  ident: bb0135
  article-title: Visualization and knowledge discovery in bibliographic databases
  publication-title: AMIA Annu. Symp. Proc.
– volume: 327
  start-page: 656
  year: 2010
  end-page: 661
  ident: bb1050
  article-title: Development of monocytes, macrophages, and dendritic cells
  publication-title: Science.
– volume: 9
  year: 2021
  ident: bb1140
  article-title: Tumor associated macrophages, as the dominant immune cells, are an indispensable target for immunologically cold tumor-glioma therapy?
  publication-title: Front. Cell Dev. Biol.
– volume: 11
  start-page: 6713
  year: 2005
  end-page: 6721
  ident: bb1305
  article-title: Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
  publication-title: Clin. Cancer Res.
– volume: 16
  year: 2020
  ident: bb0685
  article-title: Injectable liquid crystal formation system for reshaping tumor immunosuppressive microenvironment to boost antitumor immunity: postoperative chemoimmunotherapy
  publication-title: Small.
– volume: 41
  start-page: 49
  year: 2014
  end-page: 61
  ident: bb1085
  article-title: Tumor-associated macrophages: from mechanisms to therapy
  publication-title: Immunity.
– volume: 100
  start-page: 57
  year: 2000
  end-page: 70
  ident: bb0040
  article-title: The hallmarks of cancer
  publication-title: Cell.
– volume: 20
  start-page: 6957
  year: 2020
  end-page: 6965
  ident: bb0450
  article-title: Selective capture and recovery of monoclonal antibodies by self-assembling supramolecular polymers of high affinity for protein binding
  publication-title: Nano Lett.
– volume: 12
  start-page: 4147
  year: 2017
  end-page: 4162
  ident: bb0975
  article-title: iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
  publication-title: Int. J. Nanomedicine
– volume: 8
  start-page: 3357
  year: 2014
  end-page: 3366
  ident: bb0580
  article-title: Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials
  publication-title: ACS Nano
– volume: 16
  start-page: 1035
  year: 2010
  end-page: 1041
  ident: bb1255
  article-title: Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
  publication-title: Nat. Med.
– volume: 74
  start-page: 627
  year: 2021
  end-page: 637
  ident: bb1110
  article-title: Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma
  publication-title: J. Hepatol.
– volume: 12
  year: 2022
  ident: bb0175
  article-title: The global research of artificial intelligence on prostate cancer: a 22-year bibliometric analysis
  publication-title: Front. Oncol.
– volume: 42
  start-page: 1938
  year: 2016
  end-page: 1944
  ident: bb0440
  article-title: RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma
  publication-title: Drug Dev. Ind. Pharm.
– volume: 2
  start-page: 751
  year: 2007
  end-page: 760
  ident: bb0050
  article-title: Nanocarriers as an emerging platform for cancer therapy
  publication-title: Nat. Nanotechnol.
– volume: 11
  start-page: 85
  year: 2011
  end-page: 95
  ident: bb0345
  article-title: Regulation of cancer cell metabolism
  publication-title: Nat. Rev. Cancer
– volume: 7
  start-page: 3276
  year: 2017
  end-page: 3292
  ident: bb1310
  article-title: Biodegradable hollow mesoporous silica nanoparticles for regulating tumor microenvironment and enhancing antitumor efficiency
  publication-title: Theranostics
– volume: 327
  start-page: 291
  year: 2010
  end-page: 295
  ident: bb1045
  article-title: Regulation of adaptive immunity by the innate immune system
  publication-title: Science.
– volume: 11
  start-page: 622
  year: 2020
  ident: bb1215
  article-title: Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
  publication-title: Nat. Commun.
– volume: 645
  start-page: 106
  year: 2017
  end-page: 112
  ident: bb1100
  article-title: Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma
  publication-title: Neurosci. Lett.
– volume: 157
  start-page: 142
  year: 2020
  end-page: 160
  ident: bb0420
  article-title: Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
  publication-title: Adv. Drug Deliv. Rev.
– volume: 1
  start-page: 462
  year: 1987
  end-page: 468
  ident: bb0385
  article-title: Trafficking of lysosomal enzymes
  publication-title: FASEB J.
– volume: 3
  start-page: 32
  year: 2018
  ident: bb0940
  article-title: Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin
  publication-title: Signal. Transduct. Target Ther.
– volume: 16
  year: 2020
  ident: bb1160
  article-title: A biomimetic polymer magnetic nanocarrier polarizing tumor-associated macrophages for potentiating immunotherapy
  publication-title: Small.
– volume: 21
  start-page: 1427
  year: 2020
  end-page: 1436
  ident: bb0505
  article-title: Enhancement of loading efficiency by coloading of doxorubicin and quercetin in thermoresponsive polymeric micelles
  publication-title: Biomacromolecules.
– volume: 8
  start-page: 3636
  year: 2014
  end-page: 3645
  ident: bb1275
  article-title: Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment
  publication-title: ACS Nano
– volume: 206
  start-page: 122
  year: 2015
  end-page: 130
  ident: bb1280
  article-title: Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle
  publication-title: J. Control. Release
– volume: 58
  start-page: 13794
  year: 2019
  end-page: 13798
  ident: bb0720
  article-title: A Camptothecin-grafted DNA tetrahedron as a precise nanomedicine to inhibit tumor growth
  publication-title: Angew. Chem. Int. Ed. Eng.
– volume: 9
  start-page: 198
  year: 2020
  ident: bb0555
  article-title: Harmonic information transitions of spatiotemporal metasurfaces
  publication-title: Light Sci. Appl.
– volume: 112
  start-page: 153
  year: 2017
  end-page: 163
  ident: bb1125
  article-title: Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment
  publication-title: Biomaterials.
– volume: 16
  start-page: 3268
  year: 2016
  end-page: 3277
  ident: bb1265
  article-title: Hyaluronidase embedded in nanocarrier PEG Shell for enhanced tumor penetration and highly efficient antitumor efficacy
  publication-title: Nano Lett.
– volume: 81
  start-page: 306
  year: 2021
  ident: bb0595
  article-title: Abstract 306: cationic cholesterol liposomes for combination therapy to treat drug-resistant ovarian cancer
  publication-title: Cancer Res.
– volume: 11
  start-page: 1905
  year: 2019
  ident: bb0490
  article-title: Transferrin-conjugated docetaxel-PLGA nanoparticles for tumor targeting: influence on MCF-7 cell cycle
  publication-title: Polymers.
– volume: 17
  year: 2021
  ident: bb0575
  article-title: Exosomal miRNA profiling to identify nanoparticle phagocytic mechanisms
  publication-title: Small.
– volume: 21
  start-page: 5212
  year: 2015
  end-page: 5224
  ident: bb0090
  article-title: Nanoparticles in ocular drug delivery systems for topical administration: promises and challenges
  publication-title: Curr. Pharm. Des.
– volume: 540
  start-page: 66
  year: 2019
  end-page: 77
  ident: bb0995
  article-title: Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery
  publication-title: J. Colloid Interface Sci.
– volume: 172
  start-page: 71
  year: 2019
  end-page: 83
  ident: bb0560
  article-title: Exosomes and their implications in central nervous system tumor biology
  publication-title: Prog. Neurobiol.
– volume: 10
  start-page: 3223
  year: 2010
  end-page: 3230
  ident: bb0055
  article-title: Nanotechnology in drug delivery and tissue engineering: from discovery to applications
  publication-title: Nano Lett.
– volume: 13
  start-page: 259
  year: 2019
  ident: bb0120
  article-title: Publication trends for Alzheimer’s disease worldwide and in China: a 30-year bibliometric analysis
  publication-title: Front. Hum. Neurosci.
– volume: 169
  start-page: 171
  year: 2013
  end-page: 179
  ident: bb0310
  article-title: Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release
  publication-title: J. Control. Release
– volume: 2
  start-page: 889
  year: 2008
  end-page: 896
  ident: bb0215
  article-title: Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
  publication-title: ACS Nano
– volume: 877
  year: 2020
  ident: bb1115
  article-title: Macrophage M1/M2 polarization
  publication-title: Eur. J. Pharmacol.
– volume: 10
  start-page: 4761
  year: 2019
  end-page: 4775
  ident: bb0485
  article-title: Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
  publication-title: Oncotarget.
– volume: 10
  start-page: 4418
  year: 2019
  ident: bb0680
  article-title: Near-infrared light and tumor microenvironment dual responsive size-switchable nanocapsules for multimodal tumor theranostics
  publication-title: Nat. Commun.
– volume: 574
  start-page: 228
  year: 2019
  end-page: 232
  ident: bb0465
  article-title: Self-coalescing flows in microfluidics for pulse-shaped delivery of reagents
  publication-title: Nature.
– volume: 27
  start-page: 582
  year: 2019
  end-page: 589
  ident: bb0475
  article-title: Transport and delivery of interferon-α through epithelial tight junctions via pH-responsive poly (methacrylic acid-grafted-ethylene glycol) nanoparticles
  publication-title: J. Drug Target.
– volume: 5
  start-page: 709
  year: 2005
  end-page: 711
  ident: bb0210
  article-title: Immunotargeted nanoshells for integrated cancer imaging and therapy
  publication-title: Nano Lett.
– volume: 15
  start-page: 2439
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0530
  article-title: Novel drug delivery systems for loading of natural plant extracts and their biomedical applications
  publication-title: Int. J. Nanomedicine
  doi: 10.2147/IJN.S227805
– volume: 10
  start-page: 4761
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0485
  article-title: Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.27109
– volume: 9
  start-page: 198
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0555
  article-title: Harmonic information transitions of spatiotemporal metasurfaces
  publication-title: Light Sci. Appl.
  doi: 10.1038/s41377-020-00441-1
– volume: 9
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb1140
  article-title: Tumor associated macrophages, as the dominant immune cells, are an indispensable target for immunologically cold tumor-glioma therapy?
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2021.706286
– volume: 329
  start-page: 645
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb1155
  article-title: Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2020.10.001
– volume: 2
  start-page: 751
  year: 2007
  ident: 10.1016/j.jconrel.2022.10.023_bb0050
  article-title: Nanocarriers as an emerging platform for cancer therapy
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2007.387
– volume: 14
  start-page: 1627
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0745
  article-title: Therapeutic nanocarriers with hydrogen peroxide-triggered drug release for cancer treatment
  publication-title: Biomacromolecules.
  doi: 10.1021/bm4002574
– volume: 16
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1160
  article-title: A biomimetic polymer magnetic nanocarrier polarizing tumor-associated macrophages for potentiating immunotherapy
  publication-title: Small.
  doi: 10.1002/smll.202003543
– volume: 15
  start-page: 220
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0870
  article-title: hGC33-modified and Sorafenib-loaded nanoparticles have a synergistic anti-Hepatoma effect by inhibiting Wnt Signaling pathway
  publication-title: Nanoscale Res. Lett.
  doi: 10.1186/s11671-020-03451-5
– volume: 15
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0945
  article-title: Direct nucleus-targeted drug delivery using cascade pHe /photo dual-sensitive polymeric nanocarrier for cancer therapy
  publication-title: Small.
  doi: 10.1002/smll.201902022
– volume: 8
  start-page: 816
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0125
  article-title: A bibliometric analysis using VOSviewer of publications on COVID-19
  publication-title: Ann. Transl. Med.
  doi: 10.21037/atm-20-4235
– volume: 11
  start-page: 2226
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0445
  article-title: Implementation of the emulsification-diffusion method by solvent displacement for polystyrene nanoparticles prepared from recycled material
  publication-title: RSC Adv.
  doi: 10.1039/D0RA07749F
– volume: 877
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1115
  article-title: Macrophage M1/M2 polarization
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2020.173090
– volume: 69
  start-page: 351
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0005
  article-title: The American Cancer Society 2035 challenge goal on cancer mortality reduction
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21564
– volume: 16
  start-page: 599
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb1175
  article-title: Regulatory circuits of T cell function in cancer
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2016.80
– volume: 10
  start-page: 257
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb0435
  article-title: Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer
  publication-title: Int. J. Nanomedicine
– volume: 538
  start-page: 630
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0860
  article-title: Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer
  publication-title: J. Colloid Interface Sci.
  doi: 10.1016/j.jcis.2018.12.032
– volume: 66
  start-page: 2
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb0290
  article-title: Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2013.11.009
– volume: 81
  start-page: 306
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0595
  article-title: Abstract 306: cationic cholesterol liposomes for combination therapy to treat drug-resistant ovarian cancer
  publication-title: Cancer Res.
  doi: 10.1158/1538-7445.AM2021-306
– volume: 1
  start-page: 480
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0640
  article-title: Redox stimuli-responsive hollow mesoporous silica nanocarriers for targeted drug delivery in cancer therapy
  publication-title: Nanosc. Horiz.
  doi: 10.1039/C6NH00139D
– volume: 14
  start-page: 4890
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0795
  article-title: Enzyme-triggered Transcytosis of dendrimer-drug conjugate for deep penetration into pancreatic Tumors
  publication-title: ACS Nano
  doi: 10.1021/acsnano.0c00974
– volume: 367
  start-page: eaau6977
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0545
  article-title: The biology, function, and biomedical applications of exosomes
  publication-title: Science.
  doi: 10.1126/science.aau6977
– volume: 11
  start-page: 622
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1215
  article-title: Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-14425-7
– volume: 608
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0105
  article-title: Advances and challenges in the nanoparticles-laden contact lenses for ocular drug delivery
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2021.121090
– volume: 327
  start-page: 291
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb1045
  article-title: Regulation of adaptive immunity by the innate immune system
  publication-title: Science.
  doi: 10.1126/science.1183021
– volume: 577
  start-page: 561
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1230
  article-title: Tertiary lymphoid structures improve immunotherapy and survival in melanoma
  publication-title: Nature.
  doi: 10.1038/s41586-019-1914-8
– volume: 111
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0470
  article-title: Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles
  publication-title: Mater. Sci. Eng. C Mater. Biol. Appl.
  doi: 10.1016/j.msec.2020.110768
– volume: 27
  start-page: 582
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0475
  article-title: Transport and delivery of interferon-α through epithelial tight junctions via pH-responsive poly (methacrylic acid-grafted-ethylene glycol) nanoparticles
  publication-title: J. Drug Target.
  doi: 10.1080/1061186X.2018.1547732
– volume: 6
  year: 2011
  ident: 10.1016/j.jconrel.2022.10.023_bb0240
  article-title: Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo
  publication-title: PLoS One
– volume: 194
  start-page: 1060
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0015
  article-title: Radiation-induced morphea-a rare but severe late effect of adjuvant breast irradiation: case report and review of the literature
  publication-title: Strahlenther. Onkol.
  doi: 10.1007/s00066-018-1336-9
– volume: 10
  start-page: 767
  year: 2011
  ident: 10.1016/j.jconrel.2022.10.023_bb0350
  article-title: Interfering with pH regulation in tumours as a therapeutic strategy
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd3554
– volume: 72
  start-page: 102
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb0035
  article-title: Chemotherapy
  publication-title: Nihon Rinsho
– volume: 32
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0840
  article-title: Ligand-installed Nanocarriers toward precision therapy
  publication-title: Adv. Mater.
– volume: 20
  start-page: 3039
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0800
  article-title: Photoactivatable prodrug-backboned polymeric nanoparticles for efficient light-controlled gene delivery and synergistic treatment of platinum-resistant ovarian cancer
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.9b04981
– volume: 1
  start-page: FDD8
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0875
  article-title: Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
  publication-title: Future Drug Discov.
  doi: 10.4155/fdd-2019-0005
– volume: 79
  start-page: 949
  year: 1990
  ident: 10.1016/j.jconrel.2022.10.023_bb0010
  article-title: Drug targeting in cancer chemotherapy: a clinical perspective
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600791102
– volume: 624
  start-page: 25
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb0425
  article-title: Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-60761-609-2_3
– volume: 10
  start-page: 3838
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0690
  article-title: Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-11718-4
– volume: 27
  start-page: 1482
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb1205
  article-title: Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
  publication-title: Ann. Oncol.
  doi: 10.1093/annonc/mdw168
– volume: 234
  start-page: 8509
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1130
  article-title: CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.27782
– volume: 13
  start-page: 259
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0120
  article-title: Publication trends for Alzheimer’s disease worldwide and in China: a 30-year bibliometric analysis
  publication-title: Front. Hum. Neurosci.
  doi: 10.3389/fnhum.2019.00259
– volume: 17
  start-page: 3282
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0320
  article-title: Bioresponsive polyoxometalate cluster for redox-activated photoacoustic imaging-guided photothermal cancer therapy
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.7b00995
– volume: 206
  start-page: 122
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb1280
  article-title: Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2015.03.023
– volume: 11
  start-page: 85
  year: 2011
  ident: 10.1016/j.jconrel.2022.10.023_bb0345
  article-title: Regulation of cancer cell metabolism
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2981
– volume: 4
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0160
  article-title: Document co-citation analysis to enhance transdisciplinary research
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.1701130
– volume: 114
  start-page: 206
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb1135
  article-title: Progress in tumor-associated macrophage (TAM)-targeted therapeutics
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2017.04.010
– volume: 10
  start-page: 8956
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb1315
  article-title: Synergistic transcutaneous immunotherapy enhances antitumor immune responses through delivery of checkpoint inhibitors
  publication-title: ACS Nano
  doi: 10.1021/acsnano.6b04989
– volume: 148
  start-page: 135
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb0835
  article-title: To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2010.08.027
– volume: 546
  start-page: 498
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0585
  article-title: Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
  publication-title: Nature.
  doi: 10.1038/nature22341
– volume: 15
  start-page: 138
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1170
  article-title: Multiwalled carbon nanotubes prevent tumor metastasis through switching M2-polarized macrophages to M1 via TLR4 activation
  publication-title: J. Biomed. Nanotechnol.
  doi: 10.1166/jbn.2019.2661
– volume: 32
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0360
  article-title: A multistage cooperative Nanoplatform enables intracellular co-delivery of proteins and chemotherapeutics for cancer therapy
  publication-title: Adv. Mater.
  doi: 10.1002/adma.202000013
– volume: 14
  start-page: 17365
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0910
  article-title: Hierarchical fabrication of DNA wireframe Nanoarchitectures for efficient cancer imaging and targeted therapy
  publication-title: ACS Nano
  doi: 10.1021/acsnano.0c07495
– volume: 110
  start-page: 406
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0880
  article-title: Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2017.10.113
– volume: 25
  start-page: 1596
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0955
  article-title: Circulating lipoproteins: a Trojan horse guiding squalenoylated drugs to LDL-accumulating cancer cells
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2017.05.016
– volume: 16
  start-page: 1035
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb1255
  article-title: Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
  publication-title: Nat. Med.
  doi: 10.1038/nm.2198
– volume: 14
  start-page: 17
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0885
  article-title: PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells
  publication-title: Int. J. Nanomedicine
  doi: 10.2147/IJN.S175340
– volume: 350
  start-page: 122
  year: 2022
  ident: 10.1016/j.jconrel.2022.10.023_bb0610
  article-title: Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapy
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2022.08.015
– volume: 3
  start-page: 16
  year: 2009
  ident: 10.1016/j.jconrel.2022.10.023_bb0305
  article-title: Impact of nanotechnology on drug delivery
  publication-title: ACS Nano
  doi: 10.1021/nn900002m
– volume: 13
  start-page: 240
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0025
  article-title: Modified Fe3O4 magnetic nanoparticle delivery of CpG inhibits tumor growth and spontaneous pulmonary metastases to enhance immunotherapy
  publication-title: Nanoscale Res. Lett.
  doi: 10.1186/s11671-018-2661-8
– volume: 166
  start-page: 13
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0245
  article-title: Systemic study of solvent-assisted active loading of gambogic acid into liposomes and its formulation optimization for improved delivery
  publication-title: Biomaterials.
  doi: 10.1016/j.biomaterials.2018.03.004
– volume: 11
  start-page: 594
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0970
  article-title: Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-14036-x
– volume: 11
  start-page: 2396
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0715
  article-title: A review of existing strategies for designing long-acting parenteral formulations: focus on underlying mechanisms, and future perspectives
  publication-title: Acta Pharm. Sin. B
  doi: 10.1016/j.apsb.2021.05.002
– volume: 31
  start-page: 359
  year: 2006
  ident: 10.1016/j.jconrel.2022.10.023_bb0695
  article-title: Polymer-drug conjugates: progress in polymeric prodrugs
  publication-title: Prog. Polym. Sci.
  doi: 10.1016/j.progpolymsci.2005.09.004
– volume: 25
  start-page: 268
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb1200
  article-title: Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2013.02.009
– volume: 12
  start-page: 813
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb1185
  article-title: In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2017.57
– volume: 29
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0650
  article-title: Cancer stem cell-platelet hybrid membrane-coated magnetic nanoparticles for enhanced photothermal therapy of head and neck squamous cell carcinoma
  publication-title: Adv. Funct.
– volume: 31
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1005
  article-title: Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells
  publication-title: Nanotechnology.
  doi: 10.1088/1361-6528/ab9395
– volume: 30
  start-page: 2231
  year: 2009
  ident: 10.1016/j.jconrel.2022.10.023_bb0285
  article-title: Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups
  publication-title: Biomaterials.
  doi: 10.1016/j.biomaterials.2009.01.005
– volume: 133
  start-page: 6825
  year: 2011
  ident: 10.1016/j.jconrel.2022.10.023_bb0205
  article-title: Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja2010175
– volume: 12
  year: 2022
  ident: 10.1016/j.jconrel.2022.10.023_bb0175
  article-title: The global research of artificial intelligence on prostate cancer: a 22-year bibliometric analysis
  publication-title: Front. Oncol.
– volume: 14
  start-page: 14164
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0520
  article-title: Engineering of cascade-responsive nanoplatform to inhibit lactate efflux for enhanced tumor chemo-immunotherapy
  publication-title: ACS Nano
  doi: 10.1021/acsnano.0c07071
– volume: 724–728
  year: 2005
  ident: 10.1016/j.jconrel.2022.10.023_bb0135
  article-title: Visualization and knowledge discovery in bibliographic databases
  publication-title: AMIA Annu. Symp. Proc.
– volume: 8
  start-page: 32688
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0635
  article-title: A protein-polymer bioconjugate-coated upconversion nanosystem for simultaneous tumor cell imaging, photodynamic therapy, and chemotherapy
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.6b11803
– volume: 143
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0155
  article-title: Co-authorship network analysis in cardiovascular research utilizing machine learning (2009-2019)
  publication-title: Int. J. Med. Inform.
  doi: 10.1016/j.ijmedinf.2020.104274
– volume: 33
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0670
  article-title: Supramolecular nanofibrils formed by coassembly of clinically approved drugs for tumor photothermal immunotherapy
  publication-title: Adv. Mater.
– volume: 10
  start-page: 3318
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb0190
  article-title: Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy
  publication-title: Nano Lett.
  doi: 10.1021/nl100996u
– volume: 7
  start-page: 6782
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0330
  article-title: Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect
  publication-title: ACS Nano
  doi: 10.1021/nn4017179
– volume: 339
  start-page: 114
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0615
  article-title: NIR-activated self-sensitized polymeric micelles for enhanced cancer chemo-photothermal therapy
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2021.09.017
– volume: 26
  start-page: 1
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0985
  article-title: Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
  publication-title: Drug Deliv.
  doi: 10.1080/10717544.2018.1556359
– volume: 31
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1150
  article-title: Tailoring nanomaterials for targeting tumor-associated macrophages
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201808303
– volume: 139
  start-page: 91
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0030
  article-title: Curcumin in combination with anti-cancer drugs: a nanomedicine review
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2018.11.005
– volume: 169
  start-page: 171
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0310
  article-title: Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2013.01.001
– volume: 577
  start-page: 549
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1225
  article-title: B cells and tertiary lymphoid structures promote immunotherapy response
  publication-title: Nature.
  doi: 10.1038/s41586-019-1922-8
– volume: 11
  start-page: 13078
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0730
  article-title: Enhancement of ultralow-intensity NIR light-triggered photodynamic therapy based on exo- and endogenous synergistic effects through combined glutathione-depletion chemotherapy
  publication-title: Nanoscale.
  doi: 10.1039/C9NR03052B
– volume: 142
  start-page: 1265
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0925
  article-title: Precision-guided missile-like DNA nanostructure containing warhead and guidance control for Aptamer-based targeted drug delivery into cancer cells in vitro and in vivo
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.9b09782
– volume: 58
  start-page: 14134
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0370
  article-title: Programmed release of dihydroartemisinin for synergistic cancer therapy using a CaCO3 mineralized metal-organic framework
  publication-title: Angew. Chem. Int. Ed. Eng.
  doi: 10.1002/anie.201907388
– volume: 12
  start-page: 4271
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb0220
  article-title: Negligible particle-specific antibacterial activity of silver nanoparticles
  publication-title: Nano Lett.
  doi: 10.1021/nl301934w
– volume: 9
  start-page: 2593
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1190
  article-title: Making CAR T cells a solid option for solid Tumors
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.02593
– volume: 122
  start-page: 31
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0100
  article-title: Nanoparticles for drug delivery to the anterior segment of the eye
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2017.04.001
– volume: 172
  start-page: 71
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0560
  article-title: Exosomes and their implications in central nervous system tumor biology
  publication-title: Prog. Neurobiol.
  doi: 10.1016/j.pneurobio.2018.06.006
– volume: 17
  start-page: 761
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1080
  article-title: Biomaterial-assisted targeted modulation of immune cells in cancer treatment
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-018-0147-9
– volume: 30
  start-page: 1905758
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0365
  article-title: NIR/ROS in esponsive black phosphorus QD vesicles as Immunoadjuvant carrier for specific cancer photodynamic immunotherapy
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201905758
– volume: 21
  start-page: 9123
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0845
  article-title: Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21239123
– volume: 30
  start-page: 2003757
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0390
  article-title: pH/Cathepsin B hierarchical-responsive nanoconjugates for enhanced tumor penetration and chemo-immunotherapy
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.202003757
– volume: 1223
  start-page: 155
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1095
  article-title: CD200-CD200R pathway in the regulation of tumor immune microenvironment and immunotherapy
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-3-030-35582-1_8
– volume: 42
  start-page: 1938
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0440
  article-title: RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.1080/03639045.2016.1185435
– volume: 13
  start-page: 1164
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0460
  article-title: Stimuli-responsive hydrogels for cancer treatment: the role of pH, light, ionic strength and magnetic field
  publication-title: Cancers
  doi: 10.3390/cancers13051164
– volume: 17
  start-page: 686
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1300
  article-title: Scavenger receptor type B1 and lipoprotein nanoparticle inhibit myeloid-derived suppressor cells
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-17-0981
– volume: 71
  start-page: 3364
  year: 2011
  ident: 10.1016/j.jconrel.2022.10.023_bb0235
  article-title: Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-4261
– volume: 8
  start-page: 6765
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1330
  article-title: Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy
  publication-title: J. Mater. Chem. B
  doi: 10.1039/D0TB00649A
– volume: 11
  start-page: 108
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0660
  article-title: Evaluation of apoptotic effects of mPEG-b-PLGA coated iron oxide nanoparticles as a eupatorin carrier on DU-145 and LNCaP human prostate cancer cell lines
  publication-title: J. Pharm. Biomed.
– volume: 86
  start-page: 395
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0865
  article-title: Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2019.01.025
– volume: 12
  start-page: 844
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb0195
  article-title: Graphene quantum dots derived from carbon fibers
  publication-title: Nano Lett.
  doi: 10.1021/nl2038979
– volume: 11
  start-page: 1905
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0490
  article-title: Transferrin-conjugated docetaxel-PLGA nanoparticles for tumor targeting: influence on MCF-7 cell cycle
  publication-title: Polymers.
  doi: 10.3390/polym11111905
– volume: 328
  start-page: 65
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb1090
  article-title: The role of CD200-CD200R in tumor immune evasion
  publication-title: J. Theor. Biol.
  doi: 10.1016/j.jtbi.2013.03.017
– volume: 307
  start-page: 1630
  year: 2005
  ident: 10.1016/j.jconrel.2022.10.023_bb1040
  article-title: Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate
  publication-title: Science.
  doi: 10.1126/science.1108003
– volume: 146
  start-page: 660
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0655
  article-title: Erythrocyte membrane camouflaged graphene oxide for tumor-targeted photothermal-chemotherapy
  publication-title: Carbon.
  doi: 10.1016/j.carbon.2019.02.056
– volume: 46
  start-page: 3830
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0355
  article-title: Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumor microenvironment
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C6CS00592F
– volume: 195
  start-page: 206
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb0535
  article-title: Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2011.12.004
– volume: 13
  start-page: 957
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1250
  article-title: Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles
  publication-title: Int. J. Nanomedicine
  doi: 10.2147/IJN.S152742
– volume: 47
  start-page: 2084
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb0710
  article-title: Engineering responsive polymer building blocks with host-guest molecular recognition for functional applications
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar5001007
– volume: 21
  start-page: 202
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0915
  article-title: Targeted delivery of doxorubicin liposomes for her-2+ breast cancer treatment
  publication-title: AAPS PharmSciTech
  doi: 10.1208/s12249-020-01743-8
– volume: 48
  start-page: 542
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1000
  article-title: Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models
  publication-title: Artif. Cells Nanomed. Biotechnol.
  doi: 10.1080/21691401.2020.1725025
– volume: 34
  start-page: 571
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0335
  article-title: Multifunctional Fe3O4@C@ag hybrid nanoparticles as dual modal imaging probes and near-infrared light-responsive drug delivery platform
  publication-title: Biomaterials.
  doi: 10.1016/j.biomaterials.2012.10.002
– volume: 58
  start-page: 13794
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0720
  article-title: A Camptothecin-grafted DNA tetrahedron as a precise nanomedicine to inhibit tumor growth
  publication-title: Angew. Chem. Int. Ed. Eng.
  doi: 10.1002/anie.201907380
– volume: 173
  start-page: 57
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0820
  article-title: Multiple polysaccharide-drug complex-loaded liposomes: a unique strategy in drug loading and cancer targeting
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2017.05.062
– volume: 2000
  start-page: 237
  issue: 85
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0150
  article-title: A bibliometric analysis of periodontology
  publication-title: Periodontol
  doi: 10.1111/prd.12376
– volume: 64
  start-page: 1005
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb0375
  article-title: Photochemical mechanisms of light-triggered release from nanocarriers
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2012.02.006
– volume: 5
  start-page: 829
  year: 2005
  ident: 10.1016/j.jconrel.2022.10.023_bb0200
  article-title: Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer
  publication-title: Nano Lett.
  doi: 10.1021/nl050074e
– volume: 13
  start-page: 3821
  year: 2022
  ident: 10.1016/j.jconrel.2022.10.023_bb0630
  article-title: An in situ hydrogel-mediated chemo-immunometabolic cancer therapy
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-022-31579-8
– volume: 74
  start-page: 627
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb1110
  article-title: Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2020.10.021
– volume: 165
  start-page: 164
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb1015
  article-title: Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2021.05.014
– volume: 31
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1070
  article-title: Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy
  publication-title: Adv. Mater.
– volume: 12
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0145
  article-title: Bibliometric analysis of global research trends on ultrasound microbubble: a quickly developing field
  publication-title: Front. Pharmacol.
– volume: 12
  start-page: 4147
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0975
  article-title: iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
  publication-title: Int. J. Nanomedicine
  doi: 10.2147/IJN.S134148
– volume: 14
  start-page: 14919
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0455
  article-title: Ultrastable AgBiS2 hollow Nanospheres with cancer cell-specific cytotoxicity for multimodal tumor therapy
  publication-title: ACS Nano
  doi: 10.1021/acsnano.0c04370
– volume: 8
  start-page: 329
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0510
  article-title: Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer
  publication-title: Drug Deliv. Transl. Res.
  doi: 10.1007/s13346-017-0377-4
– volume: 9
  start-page: 3637
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb1035
  article-title: MRI-guided and ultrasound-triggered release of NO by advanced nanomedicine
  publication-title: Nanoscale.
  doi: 10.1039/C7NR00231A
– volume: 294
  start-page: 376
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0755
  article-title: Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2018.11.032
– volume: 137
  start-page: 6112
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb0830
  article-title: Light-triggered, self-Immolative nucleic acid-drug nanostructures
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.5b00795
– volume: 3
  start-page: 32
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0940
  article-title: Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin
  publication-title: Signal. Transduct. Target Ther.
  doi: 10.1038/s41392-018-0032-7
– volume: 16
  start-page: 193
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb1180
  article-title: T cell migration, search strategies and mechanisms
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2015.16
– volume: 29
  start-page: 4828
  year: 2011
  ident: 10.1016/j.jconrel.2022.10.023_bb1020
  article-title: Cancer immunotherapy comes of age
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2011.38.0899
– volume: 12
  start-page: 151
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0430
  article-title: PEGylation of paclitaxel-loaded cationic liposomes drives steric stabilization of Bicelles and vesicles thereby enhancing delivery and cytotoxicity to human cancer cells
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.9b16150
– volume: 7
  start-page: 2001060
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0645
  article-title: A nanomedicine fabricated from gold nanoparticles-decorated metal-organic framework for cascade chemo/chemodynamic cancer therapy
  publication-title: Adv. Sci. (Weinh.)
– volume: 65
  start-page: 1
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0700
  article-title: Prodrugs: a challenge for the drug development
  publication-title: Pharmacol. Rep.
  doi: 10.1016/S1734-1140(13)70959-9
– volume: 540
  start-page: 66
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0995
  article-title: Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery
  publication-title: J. Colloid Interface Sci.
  doi: 10.1016/j.jcis.2019.01.021
– volume: 66
  start-page: 8927
  year: 2006
  ident: 10.1016/j.jconrel.2022.10.023_bb0340
  article-title: Cancer’s molecular sweet tooth and the Warburg effect
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-1501
– volume: 143
  start-page: 1806
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1165
  article-title: Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31562
– volume: 53
  start-page: 8596
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0980
  article-title: GSH-responsive supramolecular nanoparticles constructed by β-d-galactose-modified pillar[5]arene and camptothecin prodrug for targeted anticancer drug delivery
  publication-title: Chem. Commun.
  doi: 10.1039/C7CC04932C
– volume: 6
  start-page: 470
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0895
  article-title: Polydopamine-based surface modification of novel nanoparticle-Aptamer bioconjugates for in vivo breast cancer targeting and enhanced therapeutic effects
  publication-title: Theranostics.
  doi: 10.7150/thno.14184
– volume: 8
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0410
  article-title: Nanotechnology for targeted detection and removal of bacteria: opportunities and challenges
  publication-title: Adv. Sci.
  doi: 10.1002/advs.202100556
– volume: 33
  start-page: 5776
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb1260
  article-title: Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
  publication-title: Biomaterials.
  doi: 10.1016/j.biomaterials.2012.04.029
– volume: 645
  start-page: 106
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb1100
  article-title: Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2017.02.076
– volume: 21
  start-page: 5212
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb0090
  article-title: Nanoparticles in ocular drug delivery systems for topical administration: promises and challenges
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612821666150923095155
– volume: 18
  start-page: 296
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0080
  article-title: Bibliometrics: tracking research impact by selecting the appropriate metrics
  publication-title: Asian J. Androl.
  doi: 10.4103/1008-682X.171582
– volume: 96
  start-page: 456
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0605
  article-title: Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumor-targeted therapeutic efficiency
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2019.06.051
– volume: 27
  start-page: 903
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb0825
  article-title: An Imagable and Photothermal “Abraxane-like” Nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast Tumors
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201404308
– volume: 7
  start-page: 13193
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb1055
  article-title: Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms13193
– volume: 6
  start-page: 287
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0550
  article-title: Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges
  publication-title: Acta Pharm. Sin. B
  doi: 10.1016/j.apsb.2016.02.001
– volume: 14
  start-page: 1295
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb0130
  article-title: Emerging trends and new developments in regenerative medicine: a scientometric update (2000–2014)
  publication-title: Expert. Opin. Biol. Ther.
  doi: 10.1517/14712598.2014.920813
– volume: 574
  start-page: 228
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0465
  article-title: Self-coalescing flows in microfluidics for pulse-shaped delivery of reagents
  publication-title: Nature.
  doi: 10.1038/s41586-019-1635-z
– volume: 56
  start-page: 8861
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0815
  article-title: Supramolecular nanoprodrug based on boronate ester linked curcumin complexing with water-soluble pillar[5]arene for synergistic chemotherapies
  publication-title: Chem. Commun. (Camb.)
  doi: 10.1039/D0CC04315J
– volume: 4
  start-page: 195
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1210
  article-title: Nitinol thin films functionalized with CAR-T cells for the treatment of solid tumours
  publication-title: Nat. Biomed. Eng.
  doi: 10.1038/s41551-019-0486-0
– volume: 63
  start-page: 2957
  year: 2003
  ident: 10.1016/j.jconrel.2022.10.023_bb0395
  article-title: Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy
  publication-title: Cancer Res.
– volume: 28
  start-page: 15906
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0810
  article-title: Nano-palladium is a cellular catalyst for in vivo chemistry
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms15906
– volume: 31
  start-page: 2004500
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0950
  article-title: Pulmonary targeting crosslinked cyclodextrin metal–organic frameworks for lung cancer therapy
  publication-title: Adv. Funct. Mater.
– volume: 10
  start-page: 4418
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0680
  article-title: Near-infrared light and tumor microenvironment dual responsive size-switchable nanocapsules for multimodal tumor theranostics
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-019-12142-4
– volume: 103
  start-page: 223
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0855
  article-title: Antibody-directed metal-organic framework nanoparticles for targeted drug delivery
  publication-title: Acta Biomater.
  doi: 10.1016/j.actbio.2019.12.012
– volume: 13
  start-page: 1831
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0850
  article-title: Trastuzumab- and fab’ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
  publication-title: Int. J. Nanomedicine
  doi: 10.2147/IJN.S153795
– volume: 14
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0070
  article-title: Big moment for nanotech: oncology therapeutics poised for a leap
  publication-title: OncLive
– volume: 3
  start-page: 1377
  year: 2011
  ident: 10.1016/j.jconrel.2022.10.023_bb0260
  article-title: Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier
  publication-title: Polymers.
  doi: 10.3390/polym3031377
– volume: 9
  start-page: 29496
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0765
  article-title: GSH-activatable NIR fluorescent prodrug for podophyllotoxin delivery
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.7b07091
– volume: 63
  start-page: 1996024
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0770
  article-title: Amphiphilic drug-drug conjugate for cancer therapy with combination of chemotherapeutic and antiangiogenesis drugs
  publication-title: Sci. China Chem.
– volume: 57
  start-page: 359
  year: 2006
  ident: 10.1016/j.jconrel.2022.10.023_bb0165
  article-title: Detecting and visualizing emerging trends and transient patterns in scientific literature
  publication-title: J. Am. Soc. Inf. Sci. Technol.
  doi: 10.1002/asi.20317
– volume: 2
  start-page: 750
  year: 2002
  ident: 10.1016/j.jconrel.2022.10.023_bb0020
  article-title: Ligand-targeted therapeutics in anticancer therapy
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc903
– volume: 157
  start-page: 142
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0420
  article-title: Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2020.06.005
– volume: 83
  start-page: 28
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0890
  article-title: EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2015.12.014
– volume: 22
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0405
  article-title: The international society of RNA nanotechnology and Nanomedicine (ISRNN): the present and future of the burgeoning field
  publication-title: ACS Nano
– volume: 13
  start-page: 3256
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0265
  article-title: Chitosan: an overview of its properties and applications
  publication-title: Polymers.
  doi: 10.3390/polym13193256
– volume: 11
  start-page: 6713
  year: 2005
  ident: 10.1016/j.jconrel.2022.10.023_bb1305
  article-title: Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-05-0883
– volume: 140
  start-page: 16413
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1195
  article-title: Reprogramming exosomes as nanoscale controllers of cellular immunity
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.8b10047
– volume: 41
  start-page: 2590
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb0270
  article-title: ChemInform abstract: mesoporous silica nanoparticles in biomedical applications
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/c1cs15246g
– volume: 5
  start-page: 709
  year: 2005
  ident: 10.1016/j.jconrel.2022.10.023_bb0210
  article-title: Immunotargeted nanoshells for integrated cancer imaging and therapy
  publication-title: Nano Lett.
  doi: 10.1021/nl050127s
– volume: 17
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0575
  article-title: Exosomal miRNA profiling to identify nanoparticle phagocytic mechanisms
  publication-title: Small.
– volume: 7
  start-page: 352
  year: 2022
  ident: 10.1016/j.jconrel.2022.10.023_bb0565
  article-title: Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment
  publication-title: Nanosc. Horiz.
  doi: 10.1039/D1NH00637A
– volume: 111
  start-page: 1103
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1105
  article-title: Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
  publication-title: Cancer Sci.
  doi: 10.1111/cas.14328
– volume: 1
  start-page: 462
  year: 1987
  ident: 10.1016/j.jconrel.2022.10.023_bb0385
  article-title: Trafficking of lysosomal enzymes
  publication-title: FASEB J.
  doi: 10.1096/fasebj.1.6.3315809
– volume: 30
  start-page: 2005918
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0750
  article-title: ROS-responsive camptothecin prodrug nanoparticles for on-demand drug release and combination of chemotherapy and photodynamic therapy
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.202005918
– volume: 15
  start-page: 3640
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb0255
  article-title: An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms15033640
– volume: 46
  start-page: 1095
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0500
  article-title: Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment
  publication-title: Artif. Cells Nanomed. Biotechnol.
  doi: 10.1080/21691401.2017.1376675
– volume: 20
  start-page: 6957
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0450
  article-title: Selective capture and recovery of monoclonal antibodies by self-assembling supramolecular polymers of high affinity for protein binding
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.0c01297
– volume: 98
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0110
  article-title: Top-100 highest-cited original articles in inflammatory bowel disease: a bibliometric analysis
  publication-title: Medicine.
– volume: 8
  start-page: 3357
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb0580
  article-title: Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials
  publication-title: ACS Nano
  doi: 10.1021/nn405830g
– volume: 130
  start-page: 2382
  year: 2008
  ident: 10.1016/j.jconrel.2022.10.023_bb0315
  article-title: Enzyme-responsive snap-top covered silica nanocontainers
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja0772086
– volume: 82
  start-page: 545
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb0540
  article-title: Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2012.08.012
– volume: 29
  start-page: 692
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0115
  article-title: The top 100 most-cited papers in paediatric dentistry journals: a bibliometric analysis
  publication-title: Int. J. Paediatr. Dent.
  doi: 10.1111/ipd.12563
– volume: 18
  start-page: 242
  year: 2022
  ident: 10.1016/j.jconrel.2022.10.023_bb0620
  article-title: On-demand assembly of polymeric nanoparticles for longer-blood-circulation and disassembly in tumor for boosting sonodynamic therapy
  publication-title: Bioact. Mater.
  doi: 10.1016/j.bioactmat.2022.03.009
– volume: 5
  start-page: 161
  year: 2005
  ident: 10.1016/j.jconrel.2022.10.023_bb0045
  article-title: Cancer nanotechnology: opportunities and challenges
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1566
– volume: 337
  start-page: 179
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0625
  article-title: Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2021.07.018
– volume: 12
  start-page: 1004
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0065
  article-title: Macroscale delivery systems for molecular and cellular payloads
  publication-title: Nat. Mater.
  doi: 10.1038/nmat3758
– volume: 4
  start-page: 807
  year: 2022
  ident: 10.1016/j.jconrel.2022.10.023_bb0665
  article-title: Tumor-anchoring drug-loaded fibrous microspheres for MR imaging-guided local chemotherapy and metastasis inhibition
  publication-title: Adv. Fiber Mater.
  doi: 10.1007/s42765-022-00137-8
– volume: 29
  start-page: 1805582
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0775
  article-title: Ultralong circulating lollipop-like nanoparticles assembled with gossypol, doxorubicin, and Polydopamine via π-π stacking for synergistic tumor therapy
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201805582
– volume: 1
  start-page: 203
  year: 2008
  ident: 10.1016/j.jconrel.2022.10.023_bb0180
  article-title: Nano-graphene oxide for cellular imaging and drug delivery
  publication-title: Nano Res.
  doi: 10.1007/s12274-008-8021-8
– volume: 10
  start-page: 3223
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb0055
  article-title: Nanotechnology in drug delivery and tissue engineering: from discovery to applications
  publication-title: Nano Lett.
  doi: 10.1021/nl102184c
– volume: 10
  start-page: 2778
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1325
  article-title: Carrier-free nano-integrated strategy for synergetic cancer anti-angiogenic therapy and phototherapy
  publication-title: Chem. Sci.
  doi: 10.1039/C8SC04123G
– volume: 2
  start-page: 889
  year: 2008
  ident: 10.1016/j.jconrel.2022.10.023_bb0215
  article-title: Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery
  publication-title: ACS Nano
  doi: 10.1021/nn800072t
– volume: 9
  start-page: 101
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb0325
  article-title: Emerging applications of stimuli-responsive polymer materials
  publication-title: Nat. Mater.
  doi: 10.1038/nmat2614
– volume: 13
  start-page: 10939
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0480
  article-title: Mucosal immunization with a pH-responsive nanoparticle vaccine induces protective CD8+ lung-resident memory T cells
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b00326
– volume: 112
  start-page: 153
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb1125
  article-title: Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment
  publication-title: Biomaterials.
  doi: 10.1016/j.biomaterials.2016.09.034
– volume: 3
  start-page: 1598
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0495
  article-title: Glucose and H2O2 dual-responsive polymeric micelles for the self-regulated release of insulin
  publication-title: ACS Appl. Bio Mater.
  doi: 10.1021/acsabm.9b01185
– volume: 140
  start-page: 11
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0785
  article-title: Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery
  publication-title: Colloids Surf. B: Biointerfaces
  doi: 10.1016/j.colsurfb.2015.12.025
– volume: 29
  start-page: 1902440
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1060
  article-title: Hyaluronidase with Ph-responsive dextran modification as an adjuvant nanomedicine for enhanced photodynamic-immunotherapy of cancer
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201902440
– volume: 9
  start-page: 16365
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0965
  article-title: EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy
  publication-title: Nanoscale.
  doi: 10.1039/C7NR06898K
– volume: 10
  start-page: 10636
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb1285
  article-title: Gold nanoparticle reprograms pancreatic tumor microenvironment and inhibits tumor growth
  publication-title: ACS Nano
  doi: 10.1021/acsnano.6b02231
– volume: 33
  start-page: 3235
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb0675
  article-title: Antitumor immunologically modified carbon nanotubes for photothermal therapy
  publication-title: Biomaterials.
  doi: 10.1016/j.biomaterials.2011.12.029
– volume: 193
  start-page: 153
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0790
  article-title: Reduction-active polymeric prodrug micelles based on α-cyclodextrin polyrotaxanes for triggered drug release and enhanced cancer therapy
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2018.03.097
– volume: 44
  start-page: 1123
  year: 2011
  ident: 10.1016/j.jconrel.2022.10.023_bb0300
  article-title: Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar200054n
– volume: 79
  start-page: 2152
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0570
  article-title: Exosomes from Nischarin-expressing cells reduce breast cancer cell motility and tumor growth
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-18-0842
– volume: 9
  start-page: 1015
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0590
  article-title: Design strategies and application progress of therapeutic exosomes
  publication-title: Theranostics.
  doi: 10.7150/thno.30853
– volume: 84
  start-page: 523
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb0085
  article-title: Software survey: VOSviewer, a computer program for bibliometric mapping
  publication-title: Scientometrics
  doi: 10.1007/s11192-009-0146-3
– volume: 13
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb1270
  article-title: Inhibiting solid tumor growth in vivo by non-tumor-penetrating nanomedicine
  publication-title: Small.
  doi: 10.1002/smll.201600954
– volume: 17
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0170
  article-title: A standardized citation metrics author database annotated for scientific field
  publication-title: PLoS Biol.
  doi: 10.1371/journal.pbio.3000384
– volume: 17
  start-page: 20
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb0415
  article-title: Cancer nanomedicine: progress, challenges and opportunities
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc.2016.108
– volume: 16
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0685
  article-title: Injectable liquid crystal formation system for reshaping tumor immunosuppressive microenvironment to boost antitumor immunity: postoperative chemoimmunotherapy
  publication-title: Small.
  doi: 10.1002/smll.202004905
– volume: 29
  start-page: 1808646
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0780
  article-title: Poly (ferulic acid) with an anticancer effect as a drug nanocarrier for enhanced colon cancer therapy
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.201808646
– volume: 14
  start-page: 2181
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb1075
  article-title: Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery
  publication-title: Nano Lett.
  doi: 10.1021/nl500618u
– volume: 15
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1065
  article-title: Cancer immunotherapy of TLR4 agonist-antigen constructs enhanced with pathogen-mimicking magnetite nanoparticles and checkpoint blockade of PD-L1
  publication-title: Small.
  doi: 10.1002/smll.201803993
– volume: 603
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0275
  article-title: Iron oxide @ gold nanoparticles: synthesis, properties and potential use as anode materials for lithium-ion batteries
  publication-title: Colloids Surf. A Physicochem. Eng. Asp.
  doi: 10.1016/j.colsurfa.2020.125178
– volume: 17
  start-page: 528
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1240
  article-title: A facile approach to enhance antigen response for personalized cancer vaccination
  publication-title: Nat. Mater.
  doi: 10.1038/s41563-018-0028-2
– volume: 16
  start-page: 5401
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0760
  article-title: Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.6b01632
– volume: 13
  start-page: 3083
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1235
  article-title: In situ dendritic cell vaccine for effective cancer immunotherapy
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b08346
– volume: 3
  start-page: 279
  year: 2009
  ident: 10.1016/j.jconrel.2022.10.023_bb0185
  article-title: Cytotoxicity and genotoxicity of silver nanoparticles in human cells
  publication-title: ACS Nano
  doi: 10.1021/nn800596w
– volume: 42
  start-page: 7289
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0705
  article-title: Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/c3cs60048c
– volume: 4
  start-page: 148rv9
  year: 2012
  ident: 10.1016/j.jconrel.2022.10.023_bb0060
  article-title: Engineering approaches to immunotherapy
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.3003763
– volume: 160
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0920
  article-title: Synthesis of Aptamer-PEI-g-PEG modified gold nanoparticles loaded with doxorubicin for targeted drug delivery
  publication-title: J. Vis. Exp.
– volume: 13
  start-page: 525
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb1025
  article-title: Gene-engineered T cells for cancer therapy
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3565
– volume: 46
  start-page: 28
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb0525
  article-title: pH-sensitive and biocompatible quercetin-loaded GO-PEA-HA carrier improved antitumour efficiency and specificity
  publication-title: Artif. Cells Nanomed. Biotechnol.
  doi: 10.1080/21691401.2018.1489261
– volume: 24
  start-page: 852
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb1295
  article-title: In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes
  publication-title: Bioconjug. Chem.
  doi: 10.1021/bc400070q
– volume: 348
  start-page: 56
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb1030
  article-title: The future of immune checkpoint therapy
  publication-title: Science.
  doi: 10.1126/science.aaa8172
– volume: 21
  start-page: 1427
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0505
  article-title: Enhancement of loading efficiency by coloading of doxorubicin and quercetin in thermoresponsive polymeric micelles
  publication-title: Biomacromolecules.
  doi: 10.1021/acs.biomac.9b01742
– volume: 174
  start-page: 416
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0805
  article-title: Ultrasound triggered phase-change nanodroplets for doxorubicin prodrug delivery and ultrasound diagnosis: an in vitro study
  publication-title: Colloids Surf. B: Biointerfaces
  doi: 10.1016/j.colsurfb.2018.11.046
– volume: 327
  start-page: 656
  year: 2010
  ident: 10.1016/j.jconrel.2022.10.023_bb1050
  article-title: Development of monocytes, macrophages, and dendritic cells
  publication-title: Science.
  doi: 10.1126/science.1178331
– volume: 7
  start-page: 773
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb1245
  article-title: In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles
  publication-title: Biomater. Sci.
  doi: 10.1039/C8BM01272E
– volume: 12
  start-page: 2673
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1320
  article-title: Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release
  publication-title: Nanoscale.
  doi: 10.1039/C9NR08558K
– volume: 8
  start-page: 10726
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0930
  article-title: cRGD-modified benzimidazole-based pH-responsive nanoparticles for enhanced tumor targeted doxorubicin delivery
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.6b01501
– volume: 413
  start-page: 36
  year: 2001
  ident: 10.1016/j.jconrel.2022.10.023_bb0250
  article-title: Immune recognition. A new receptor for beta-glucans
  publication-title: Nature.
  doi: 10.1038/35092620
– volume: 5
  start-page: 275
  year: 2005
  ident: 10.1016/j.jconrel.2022.10.023_bb0230
  article-title: Tumour stem cells and drug resistance
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1590
– volume: 28
  start-page: 4440
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0740
  article-title: Redox-hypersensitive organic nanoparticles for selective treatment of cancer cells
  publication-title: Chem. Mater.
  doi: 10.1021/acs.chemmater.6b01641
– volume: 556
  start-page: 217
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0935
  article-title: RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2018.12.023
– volume: 134
  start-page: 47
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb0990
  article-title: Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin
  publication-title: Colloids Surf. B: Biointerfaces
  doi: 10.1016/j.colsurfb.2015.06.027
– volume: 100
  start-page: 57
  year: 2000
  ident: 10.1016/j.jconrel.2022.10.023_bb0040
  article-title: The hallmarks of cancer
  publication-title: Cell.
  doi: 10.1016/S0092-8674(00)81683-9
– volume: 116
  start-page: 5338
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0075
  article-title: Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.5b00589
– volume: 13
  start-page: 1743
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb0095
  article-title: Application of lipid nanoparticles to ocular drug delivery
  publication-title: Expert. Opin. Drug Deliv.
  doi: 10.1080/17425247.2016.1201059
– volume: 359
  start-page: 1037
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1220
  article-title: Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
  publication-title: Science.
  doi: 10.1126/science.aar3246
– volume: 27
  start-page: 3944
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb1145
  article-title: Small-molecule CSF1R inhibitors as anticancer agents
  publication-title: Curr. Med. Chem.
  doi: 10.2174/1573394715666190618121649
– volume: 16
  start-page: 3268
  year: 2016
  ident: 10.1016/j.jconrel.2022.10.023_bb1265
  article-title: Hyaluronidase embedded in nanocarrier PEG Shell for enhanced tumor penetration and highly efficient antitumor efficacy
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.6b00820
– volume: 86
  start-page: 589
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb0400
  article-title: Synthesis and evaluation of a CBZ-AAN-dox prodrug and its in vitro effects on SiHa cervical cancer cells under hypoxic conditions
  publication-title: Chem. Biol. Drug Des.
  doi: 10.1111/cbdd.12525
– volume: 10
  start-page: 451
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb0380
  article-title: Photoresponsive nanoparticles for drug delivery
  publication-title: Nano Today
  doi: 10.1016/j.nantod.2015.06.004
– volume: 10
  start-page: 36862
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0515
  article-title: Functionalization of MOF-5 with mono-substituents: effects on drug delivery behavior
  publication-title: RSC Adv.
  doi: 10.1039/D0RA06106A
– volume: 141
  start-page: 20354
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0905
  article-title: Programming drug delivery kinetics for active burst release with DNA toehold switches
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.9b10765
– volume: 253
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb1010
  article-title: Lactoferrin/phenylboronic acid-functionalized hyaluronic acid nanogels loading doxorubicin hydrochloride for targeting glioma
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2020.117194
– volume: 91
  start-page: 3
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb0295
  article-title: Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2015.01.002
– volume: 8
  start-page: 137
  year: 2013
  ident: 10.1016/j.jconrel.2022.10.023_bb0225
  article-title: Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2012.237
– volume: 7
  start-page: 3276
  year: 2017
  ident: 10.1016/j.jconrel.2022.10.023_bb1310
  article-title: Biodegradable hollow mesoporous silica nanoparticles for regulating tumor microenvironment and enhancing antitumor efficiency
  publication-title: Theranostics
  doi: 10.7150/thno.19987
– volume: 213
  year: 2015
  ident: 10.1016/j.jconrel.2022.10.023_bb0725
  article-title: Glycyrrhetinic acid-decorated and reduction-sensitive micelles for targeted cancer therapy
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2015.05.124
– volume: 611
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0960
  article-title: Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells
  publication-title: Colloids Surf. A Physicochem. Eng. Asp.
– volume: 104
  start-page: 2050
  year: 2007
  ident: 10.1016/j.jconrel.2022.10.023_bb0280
  article-title: Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0608582104
– volume: 252
  year: 2021
  ident: 10.1016/j.jconrel.2022.10.023_bb0600
  article-title: Pectin co-functionalized dual layered solid lipid nanoparticle made by soluble curcumin for the targeted potential treatment of colorectal cancer
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2020.117180
– volume: 91
  start-page: 2610
  year: 2019
  ident: 10.1016/j.jconrel.2022.10.023_bb0900
  article-title: Programmable self-assembly of protein-Scaffolded DNA Nanohydrogels for tumor-targeted imaging and therapy
  publication-title: Anal. Chem.
  doi: 10.1021/acs.analchem.8b05706
– volume: 18
  start-page: 3571
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1290
  article-title: Repolarization of tumor-associated macrophages in a genetically engineered nonsmall cell lung cancer model by intraperitoneal administration of hyaluronic acid-based nanoparticles encapsulating MicroRNA-125b
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.8b00689
– volume: 21
  start-page: 921
  year: 2020
  ident: 10.1016/j.jconrel.2022.10.023_bb0735
  article-title: Glutathione and reactive oxygen species dual-responsive block copolymer prodrugs for boosting tumor site-specific drug release and enhanced antitumor efficacy
  publication-title: Biomacromolecules.
  doi: 10.1021/acs.biomac.9b01578
– volume: 33
  start-page: 133
  year: 2018
  ident: 10.1016/j.jconrel.2022.10.023_bb1120
  article-title: The role of tumor-associated macrophage in breast cancer biology
  publication-title: Histol. Histopathol.
– volume: 101
  start-page: 5303
  year: 2004
  ident: 10.1016/j.jconrel.2022.10.023_bb0140
  article-title: Searching for intellectual turning points: progressive knowledge domain visualization
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0307513100
– volume: 8
  start-page: 3636
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb1275
  article-title: Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment
  publication-title: ACS Nano
  doi: 10.1021/nn500216y
– volume: 41
  start-page: 49
  year: 2014
  ident: 10.1016/j.jconrel.2022.10.023_bb1085
  article-title: Tumor-associated macrophages: from mechanisms to therapy
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2014.06.010
SSID ssj0005347
Score 2.6739414
SecondaryResourceType review_article
Snippet The limitations of traditional cancer treatments are driving the creation and development of new nanomedicines. At present, with the rapid increase of research...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 211
SubjectTerms bibliometric analysis
Bibliometrics
biocompatible materials
Cancer
China
Humans
Immunotherapy
India
Nanomedicine
Nanoparticle
Neoplasms - therapy
Tumor Microenvironment
United States
Visualization
Title Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis
URI https://dx.doi.org/10.1016/j.jconrel.2022.10.023
https://www.ncbi.nlm.nih.gov/pubmed/36270513
https://www.proquest.com/docview/2727642181
https://www.proquest.com/docview/3153826721
Volume 352
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEA6iFy_i2_ooEcST20eSfcRbKUpVFMEWPAhL0iTQUralj0Mv_nZnNrtWD0XwthsSCDuTeezM94WQq1g2ZD_hIoiNkoGwKgkUNyJwSSylZXC8NP7veH6JOj3x-B6-b5B2iYXBtsrC9nubnlvrYqRefM36ZDCov0GwknCsCmJWLDmC-JC9DnS69vmjzYMLD5mOkgBnr1A89WFtCDnn1GIFgrEaNnkxvs4_rYs_cz90v0t2igCStvwe98iGzfbJ9atnoF7e0O4KUDW7odf0dcVNvTwgHwUfE52sQJYzqjJD59gcS8eOZioblxV3OshoH_Viektb1MNc8tl6oEcI3Ed-fxjwxCaHpHd_1213guKChaDPZTIPhJMiVNpBlBA3Hfh6Y0SkYx5KKx0GKmHIbIjFRniMHDNRTi6jIsm0NbrBj8hmNs7sCaFMOse5YcxAghLaUDGljZQGhN9UDd2sEFF-1rRfsI_jJRijtGwzG6aFNFKUBg6DNCqk9r1s4uk3_lqQlDJLf-lRCi7ir6WXpYxTOGNYOFGZHS9mKYMgDwHBSXP9HI6ug0WQUFfIsVeQ7x1DkBCD8eOn_9_cGdnGN99Ic04259OFvYBwaK6rub5XyVbr4anz8gVfVgns
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEB5S59BeSt91nyqUnLJ-SNqHejOhwWkSE6gDORSEZElgE9bGdg75952xtFl6MIHeFq0EYmc0j535PgF8L9VAzSohs9IZlUlvqswIJ7NQlUp5jsfL0v-Oy0kxvpa_bvKbAzhpsDDUVplsf7TpO2udRvrpa_ZX83n_NwYrlaCqIGXFSqgncEjsVLIDh6Oz8_Gk7fQQMqKmiyqjBS2Qp7_oLTDtXHsqQnDeoz4vLva5qH0h6M4Vnb6A5ymGZKO4zZdw4OtXcHQVSajvj9m0xVRtjtkRu2rpqe9fw59EycRWLc5yw0zt2Jb6Y9kysNrUy6bozuY1m5FqrH-wEYtIl91sO7e3hN0nin8ciNwmb-D69Of0ZJylOxaymVDVNpNBydzYgIFCOQzo7p2ThS1FrrwKFKvkOfc51RvxsQjcFTt-GVMobr2zA_EWOvWy9u-BcRWCEI5zhzlK7nPDjXVKOZT_0AzssAuy-ax6lgjI6R6MW910mi10koYmadAwSqMLvYdlq8jA8diCqpGZ_keVNHqJx5Z-a2Ss8ZhR7cTUfnm30RzjPMIEV8P9cwR5D15gTt2Fd1FBHnaMcUKJ9k98-P_NfYWn4-nlhb44m5x_hGf0JvbVfILOdn3nP2N0tLVfkvb_BXFjDJ0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+perspectives+and+trend+of+nanomedicine+in+cancer%3A+A+review+and+bibliometric+analysis&rft.jtitle=Journal+of+controlled+release&rft.au=Pei%2C+Zerong&rft.au=Chen%2C+Shuting&rft.au=Ding%2C+Liqin&rft.au=Liu%2C+Jingbo&rft.date=2022-12-01&rft.eissn=1873-4995&rft.volume=352&rft.spage=211&rft_id=info:doi/10.1016%2Fj.jconrel.2022.10.023&rft_id=info%3Apmid%2F36270513&rft.externalDocID=36270513
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon